肥猫发发 personal page - To The Moon

肥猫发发

肥猫发发

No personal profile

9Follow

1Followers

0Topic

0Badge

2021-06-14

$SkyWater Technology, Inc.(SKYT)$gogogo

2021-06-10

$ContextLogic Inc.(WISH)$to the moon

2021-06-10

Gogogo

BRIEF-AMC Entertainment Director Kathleen Pawlus Reports Open Market Sale Of 15,379 Class A Shares

2021-06-10

Gogogo

World’s Richest Face Tax Squeeze After 40% Run-Up in Fortunes

2021-06-10

Gogogo

ECB to keep money taps wide open even as recovery takes hold

2021-06-09

$ContextLogic Inc.(WISH)$gogogo

2021-06-09

$Radio One(UONE)$?

2021-06-08

$Skillz Inc(SKLZ)$gogogo

2021-06-08

Gogogo

2021-06-08

$Orbital Energy Group(OEG)$gogogo

2021-06-08

Go

FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades

2021-06-08

$Skillz Inc(SKLZ)$gogo

2021-06-08

Gogogo

Sorry, the original content has been removed

2021-06-07

Gogo

Palantir Is Sandbagging Growth Projections

2021-06-07

$Skillz Inc(SKLZ)$gogogo

2021-06-05

$SkyWater Technology, Inc.(SKYT)$ small start

2021-06-05

$Microvision(MVIS)$ finally green

2021-05-28

$Tiger Brokers(TIGR)$?

2021-04-22

$Greenwich Lifesciences Inc(GLSI)$good prospective

2021-04-16

Diamond hand

Why Zomedica Stock Plunged Thursday

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3562230741987077","uuid":"3562230741987077","gmtCreate":1599136719501,"gmtModify":1612959124212,"name":"肥猫发发","pinyin":"fmfffeimaofafa","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":9,"tweetSize":24,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.83%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.10%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":2,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":184966120,"gmtCreate":1623681230060,"gmtModify":1704208589933,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SKYT\">$SkyWater Technology, Inc.(SKYT)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/SKYT\">$SkyWater Technology, Inc.(SKYT)$</a>gogogo","text":"$SkyWater Technology, Inc.(SKYT)$gogogo","images":[{"img":"https://static.tigerbbs.com/3704c4f62374ea4eb5ab662eda4f1fb0","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184966120","isVote":1,"tweetType":1,"viewCount":277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":183345965,"gmtCreate":1623311327657,"gmtModify":1704200611863,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>to the moon","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>to the moon","text":"$ContextLogic Inc.(WISH)$to the moon","images":[{"img":"https://static.tigerbbs.com/c70e687b4721acec02f0439712d4b907","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183345965","isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":183342769,"gmtCreate":1623311288751,"gmtModify":1704200611700,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183342769","repostId":"2142248197","repostType":2,"repost":{"id":"2142248197","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623276530,"share":"https://ttm.financial/m/news/2142248197?lang=&edition=fundamental","pubTime":"2021-06-10 06:08","market":"us","language":"en","title":"BRIEF-AMC Entertainment Director Kathleen Pawlus Reports Open Market Sale Of 15,379 Class A Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2142248197","media":"Reuters","summary":"June 9 (Reuters) - AMC Entertainment Holdings Inc   :   * AMC ENTERTAINMENT'S DIRECTOR KATHLEEN PAWL","content":"<html><body><p>June 9 (Reuters) - AMC Entertainment Holdings Inc   :</p><p>   * AMC ENTERTAINMENT'S DIRECTOR KATHLEEN PAWLUS REPORTS OPEN MARKET SALE OF 15,379 CLASS A COMMON SHARES AT WEIGHTED AVERAGE PRICE OF $55.54/SHARE - FILING</p><p>Source text for Eikon: () Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-AMC Entertainment Director Kathleen Pawlus Reports Open Market Sale Of 15,379 Class A Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-AMC Entertainment Director Kathleen Pawlus Reports Open Market Sale Of 15,379 Class A Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-10 06:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>June 9 (Reuters) - AMC Entertainment Holdings Inc   :</p><p>   * AMC ENTERTAINMENT'S DIRECTOR KATHLEEN PAWLUS REPORTS OPEN MARKET SALE OF 15,379 CLASS A COMMON SHARES AT WEIGHTED AVERAGE PRICE OF $55.54/SHARE - FILING</p><p>Source text for Eikon: () Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142248197","content_text":"June 9 (Reuters) - AMC Entertainment Holdings Inc   :   * AMC ENTERTAINMENT'S DIRECTOR KATHLEEN PAWLUS REPORTS OPEN MARKET SALE OF 15,379 CLASS A COMMON SHARES AT WEIGHTED AVERAGE PRICE OF $55.54/SHARE - FILINGSource text for Eikon: () Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":260,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183342015,"gmtCreate":1623311222137,"gmtModify":1704200610240,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183342015","repostId":"1100474066","repostType":4,"repost":{"id":"1100474066","pubTimestamp":1623306645,"share":"https://ttm.financial/m/news/1100474066?lang=&edition=fundamental","pubTime":"2021-06-10 14:30","market":"us","language":"en","title":"World’s Richest Face Tax Squeeze After 40% Run-Up in Fortunes","url":"https://stock-news.laohu8.com/highlight/detail?id=1100474066","media":"bloomberg","summary":"Amazon.com Inc. founderJeff Bezoshas the resources to launch himself into space. Elon Musk does, too","content":"<p>Amazon.com Inc. founderJeff Bezoshas the resources to launch himself into space. Elon Musk does, too.</p>\n<p>In many ways, though, the world’s richest people left the rest of us behind long ago.</p>\n<p>The world’swealthiest 500individuals are now worth $8.4 trillion, up more than 40% in the year and a half since the global pandemic began its devastation. Meanwhile, the economy’s biggest winners, the tech corporations that created many of these vast fortunes, pay lower tax rates than grocery clerks, and their mega-wealthy founders can exploit legal loopholes to pass huge windfalls onto heirs largely tax-free.</p>\n<p>Taxing Talks</p>\n<p>More than 100 countries need to agree on a new framework for multinational companies</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f5ab1d945db8edf3d1450daed610c9ab\" tg-width=\"873\" tg-height=\"513\" referrerpolicy=\"no-referrer\"><span>Source: Organization for Economic Cooperation and Development Note: Data as of Feb. 2021; G-7 countries are also members of the G-20</span></p>\n<p>Now, a group powerful enough to challenge the supremacy of the tech titans is on the verge of taking action. The leaders of the Group of Seven, including U.S. President Joe Biden and U.K. Prime Minister Boris Johnson, meet in southwestern England this weekend, where they’re expected to endorse a plan to plug holes in the world’s leaky tax system.</p>\n<p>While the changes still need approval from a larger group of nations, including China, before becoming reality, the agreement by the G-7 marks a historic turning point after decades of falling levies on multinational corporations.</p>\n<p>“It is very easy for multinationals and the richest people to escape tax. What we are seeing with the G-7 is that the time has come for politicians to take back power,” said Philippe Martin, a former adviser to French President Emmanuel Macron who now heads the Conseil d’Analyse Economique. “There is a window of opportunity, a turning point at which they are realizing they need tax power and they need to spend more.”</p>\n<p>The deal would bolster Biden’s own plans to boost taxes on corporations and the wealthy by raising rates, making heirs pay more, and equalizing rates between investors and workers.</p>\n<p>The proposals are part of a global revival of initiatives to target the rich, from Buenos Aires to Stockholm to Washington, including new taxes on capital gains,inheritances, andwealththat have gained momentum since Covid-19 blew massive fiscal holes in government budgets around the world.</p>\n<p>U.S. Treasury Secretary Janet Yellen framed the G-7 deal as a way for governments to protect their national sovereignty to set tax policy.</p>\n<p>“For too long there has been a global race-to-the-bottom in corporate tax rates,” Yellen said following the G-7 finance ministers’ meeting in London last week, ahead of this weekend’s gathering.</p>\n<p>Amazon and some other tech companies, meanwhile, have endorsed the agreement, believing the global regime will be more manageable than costly alternatives being pursued by individual countries. Bezos has alsovoiced supportfor higher U.S. corporate taxes to pay for infrastructure.</p>\n<p>Advocates for higher taxes say the steps are necessary to stave off a rise in populism and even for the sustainability of capitalism.</p>\n<p>“The most visible and prominent winners of globalization are these big multinationals whose effective tax rates have collapsed,” said University of California at Berkeley economics professor Gabriel Zucman, who tracks wealth and inequality. “That can only lead to a growing rejection of that form of globalization by the people.”</p>\n<p>The World Economic Forum, the organizer of the annual conference for the rich and powerful in Davos, Switzerland, issued awhite paperthis month arguing “taxation systems must be redesigned efficiently to tax capital and multinationals.”</p>\n<p>Governments need the revenue and “progressive taxation will be an essential mechanism to compensate for the uneven recovery already under way,” according to the report.</p>\n<p>There remain plenty of defenders of low taxes.</p>\n<p>A Taxing Debate</p>\n<p>Corporate tax rates in OECD countries range from 9% to more than 30%</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e4659f086b7a925fa517b8f9026c6359\" tg-width=\"938\" tg-height=\"397\"><span>Source: Organization for Economic Cooperation and Development Note: Rates listed are combined national and provincial levies</span></p>\n<p>Conservative economists such as Douglas Holtz-Eakin, president of the American Action Forum, argue taxing the wealthy and corporations more heavily will damage the economy.</p>\n<p>“Higher taxes on capital generally raises the possibility of a slowdown of productivity growth,” said Holtz-Eakin, who was an adviser to President George W. Bush.</p>\n<p>That view is losing ground though as resentment grows over the ways that highly profitable corporations reduce their taxes.</p>\n<p>Facebook, Apple, Amazon, Netflix, Google and Microsoft collectively skirted approximately $100 billion in U.S. taxes from 2010 to 2019, according to ananalysisof regulatory filings from Fair Tax Mark, a progressive think tank. Many of those untaxed profits were shifted into tax havens like Bermuda, Ireland, Luxembourg and the Netherlands.</p>\n<p>Amazon paid an effective corporate tax rate of 11.8% in 2020, according to a Bloomberg Economicsanalysis, and it’s hardly an outlier among highly successful tech companies. Facebook, founded by the world’s fifth-richest person, Mark Zuckerberg, paid 12.2% last year.</p>\n<p>Tech’s Tax Rate</p>\n<p>Digital giants paid relatively low levels of tax on profits from 2010-2019</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1c228802d147f8d4f06faf2f76120f59\" tg-width=\"931\" tg-height=\"410\"><span>Source: Fair Tax Mark</span></p>\n<p>Asked to comment for this article, an Amazon spokesperson pointed to some of the company’s prior statements related to its tax bill, including, in part: “Amazon’s taxes, which are publicly reported, reflect our continued investments, employee compensation, and current U.S. tax laws.”</p>\n<p>As a mix between a technology company and a retailer with massive physical infrastructure, Amazon is able to use a slew of long-standing, low-profile tax preferences for stock compensation, buildings, research and development. Bezos has pushed to re-invest profits into the company, a strategy that keeps taxable income low and tax breaks high.</p>\n<p>Amazon completely avoided federal income taxes in 2017 and 2018 thanks to its savvy use of the tax code. Since then, the company has had to pay some income tax to the Internal Revenue Service, but it’s been far below the 21% headline rate installed under President Donald Trump.</p>\n<p>Billionaire tech founders often pay even less personally than their corporations do.</p>\n<p>Bezos, for example, got $77 billion richer in 2020, according to theBloomberg Billionaires Index. But in the U.S., gains on stock are only taxed when they’re sold, at a far lower rate than well-off workers pay, meaning that Bezos owed at most a few billion dollars in taxes to the U.S. Treasury last year.</p>\n<p>“This country’s wealthiest, who profited immensely during the pandemic, have not been paying their fair share,” Senate Finance Committee Chairman Ron Wyden said after ProPublicareportedon Tuesday that several of the world’s billionaires, including Bezos, didn’t pay any federal income taxes in some years.</p>\n<p>The media organization said it obtained confidential tax documents on thousands of the wealthiest Americans, including for Warren Buffett and Michael Bloomberg, owner of Bloomberg LP, the parent company of Bloomberg News. Bloomberg and others told ProPublica they had paid the taxes they owed.</p>\n<p>To remove advantages in the U.S. tax code that benefit the ultra-wealthy, Biden has proposed taxing inherited assets that currently escape levies, and boosting the top rate on investment income so that well-paid workers and investors pay the same.</p>\n<p>On an international scale, the administration is seeking a global minimum tax of at least 15% for the world’s most profitable companies -- the deal expected to be pushed forward at the G-7 meeting this weekend.</p>\n<p>Sponsored ContentThe New Auto RevolutionGAC Motor</p>\n<p>The G-7 deal would change other rules for taxing multinationals, in order to undercut efforts to shift profits to low-tax countries. Biden is also advocating to increase the U.S. corporate rate to 28%, partly reversing Trump’s tax overhaul.</p>\n<p>Race to the Bottom</p>\n<p>Worldwide average statutory corporate income tax rates have been declining for four decades</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d845bae07f165ac1814f9a4281fc2a87\" tg-width=\"936\" tg-height=\"398\"><span>Source: Tax Foundation via Atlantic Council</span></p>\n<p>Tech companies could see their effective tax rates jump if a global tax deal is reached, according to research from Morgan Stanley. Facebook and Alphabet’s Google could both pay 28% on their profits worldwide, up from 18% and 17% respectively under current rules, the report found.</p>\n<p>For all the talk of taxing the rich, Biden’s proposals, and the international tax deal, face serious hurdles before they’re adopted.</p>\n<p>While some of his fellow Democrats, who narrowly control Congress, are pushing for more radical changes to the taxes of estates and wealth, others are hesitant.</p>\n<p>The next step for the global tax negotiations, which were launched years ago by the Organization for Economic Cooperation and Development and have involved roughly 140 nations, is to win agreement among the Group of 20 countries. Finance ministers for the G-20, which collectively oversee about 90% of the world’s economy, will meet in July in Venice.</p>\n<p>Stumbling blocks to reaching a deal by year-end include China, which may seekexemptionsfrom the minimum tax.</p>\n<p>Still, there are hopes the global effort “puts an end to the craziness,” said Pascal Saint-Amans, director of the center for tax policy at the OECD. “You had loopholes everywhere and nobody was taking care of that. It’s undermining the very goal of capitalism and a free-market economy.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>World’s Richest Face Tax Squeeze After 40% Run-Up in Fortunes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWorld’s Richest Face Tax Squeeze After 40% Run-Up in Fortunes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-10 14:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-10/world-s-richest-face-a-tax-squeeze-after-40-run-up-in-fortunes><strong>bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Amazon.com Inc. founderJeff Bezoshas the resources to launch himself into space. Elon Musk does, too.\nIn many ways, though, the world’s richest people left the rest of us behind long ago.\nThe world’...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-10/world-s-richest-face-a-tax-squeeze-after-40-run-up-in-fortunes\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","MSFT":"微软","AMZN":"亚马逊"},"source_url":"https://www.bloomberg.com/news/articles/2021-06-10/world-s-richest-face-a-tax-squeeze-after-40-run-up-in-fortunes","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100474066","content_text":"Amazon.com Inc. founderJeff Bezoshas the resources to launch himself into space. Elon Musk does, too.\nIn many ways, though, the world’s richest people left the rest of us behind long ago.\nThe world’swealthiest 500individuals are now worth $8.4 trillion, up more than 40% in the year and a half since the global pandemic began its devastation. Meanwhile, the economy’s biggest winners, the tech corporations that created many of these vast fortunes, pay lower tax rates than grocery clerks, and their mega-wealthy founders can exploit legal loopholes to pass huge windfalls onto heirs largely tax-free.\nTaxing Talks\nMore than 100 countries need to agree on a new framework for multinational companies\nSource: Organization for Economic Cooperation and Development Note: Data as of Feb. 2021; G-7 countries are also members of the G-20\nNow, a group powerful enough to challenge the supremacy of the tech titans is on the verge of taking action. The leaders of the Group of Seven, including U.S. President Joe Biden and U.K. Prime Minister Boris Johnson, meet in southwestern England this weekend, where they’re expected to endorse a plan to plug holes in the world’s leaky tax system.\nWhile the changes still need approval from a larger group of nations, including China, before becoming reality, the agreement by the G-7 marks a historic turning point after decades of falling levies on multinational corporations.\n“It is very easy for multinationals and the richest people to escape tax. What we are seeing with the G-7 is that the time has come for politicians to take back power,” said Philippe Martin, a former adviser to French President Emmanuel Macron who now heads the Conseil d’Analyse Economique. “There is a window of opportunity, a turning point at which they are realizing they need tax power and they need to spend more.”\nThe deal would bolster Biden’s own plans to boost taxes on corporations and the wealthy by raising rates, making heirs pay more, and equalizing rates between investors and workers.\nThe proposals are part of a global revival of initiatives to target the rich, from Buenos Aires to Stockholm to Washington, including new taxes on capital gains,inheritances, andwealththat have gained momentum since Covid-19 blew massive fiscal holes in government budgets around the world.\nU.S. Treasury Secretary Janet Yellen framed the G-7 deal as a way for governments to protect their national sovereignty to set tax policy.\n“For too long there has been a global race-to-the-bottom in corporate tax rates,” Yellen said following the G-7 finance ministers’ meeting in London last week, ahead of this weekend’s gathering.\nAmazon and some other tech companies, meanwhile, have endorsed the agreement, believing the global regime will be more manageable than costly alternatives being pursued by individual countries. Bezos has alsovoiced supportfor higher U.S. corporate taxes to pay for infrastructure.\nAdvocates for higher taxes say the steps are necessary to stave off a rise in populism and even for the sustainability of capitalism.\n“The most visible and prominent winners of globalization are these big multinationals whose effective tax rates have collapsed,” said University of California at Berkeley economics professor Gabriel Zucman, who tracks wealth and inequality. “That can only lead to a growing rejection of that form of globalization by the people.”\nThe World Economic Forum, the organizer of the annual conference for the rich and powerful in Davos, Switzerland, issued awhite paperthis month arguing “taxation systems must be redesigned efficiently to tax capital and multinationals.”\nGovernments need the revenue and “progressive taxation will be an essential mechanism to compensate for the uneven recovery already under way,” according to the report.\nThere remain plenty of defenders of low taxes.\nA Taxing Debate\nCorporate tax rates in OECD countries range from 9% to more than 30%\nSource: Organization for Economic Cooperation and Development Note: Rates listed are combined national and provincial levies\nConservative economists such as Douglas Holtz-Eakin, president of the American Action Forum, argue taxing the wealthy and corporations more heavily will damage the economy.\n“Higher taxes on capital generally raises the possibility of a slowdown of productivity growth,” said Holtz-Eakin, who was an adviser to President George W. Bush.\nThat view is losing ground though as resentment grows over the ways that highly profitable corporations reduce their taxes.\nFacebook, Apple, Amazon, Netflix, Google and Microsoft collectively skirted approximately $100 billion in U.S. taxes from 2010 to 2019, according to ananalysisof regulatory filings from Fair Tax Mark, a progressive think tank. Many of those untaxed profits were shifted into tax havens like Bermuda, Ireland, Luxembourg and the Netherlands.\nAmazon paid an effective corporate tax rate of 11.8% in 2020, according to a Bloomberg Economicsanalysis, and it’s hardly an outlier among highly successful tech companies. Facebook, founded by the world’s fifth-richest person, Mark Zuckerberg, paid 12.2% last year.\nTech’s Tax Rate\nDigital giants paid relatively low levels of tax on profits from 2010-2019\nSource: Fair Tax Mark\nAsked to comment for this article, an Amazon spokesperson pointed to some of the company’s prior statements related to its tax bill, including, in part: “Amazon’s taxes, which are publicly reported, reflect our continued investments, employee compensation, and current U.S. tax laws.”\nAs a mix between a technology company and a retailer with massive physical infrastructure, Amazon is able to use a slew of long-standing, low-profile tax preferences for stock compensation, buildings, research and development. Bezos has pushed to re-invest profits into the company, a strategy that keeps taxable income low and tax breaks high.\nAmazon completely avoided federal income taxes in 2017 and 2018 thanks to its savvy use of the tax code. Since then, the company has had to pay some income tax to the Internal Revenue Service, but it’s been far below the 21% headline rate installed under President Donald Trump.\nBillionaire tech founders often pay even less personally than their corporations do.\nBezos, for example, got $77 billion richer in 2020, according to theBloomberg Billionaires Index. But in the U.S., gains on stock are only taxed when they’re sold, at a far lower rate than well-off workers pay, meaning that Bezos owed at most a few billion dollars in taxes to the U.S. Treasury last year.\n“This country’s wealthiest, who profited immensely during the pandemic, have not been paying their fair share,” Senate Finance Committee Chairman Ron Wyden said after ProPublicareportedon Tuesday that several of the world’s billionaires, including Bezos, didn’t pay any federal income taxes in some years.\nThe media organization said it obtained confidential tax documents on thousands of the wealthiest Americans, including for Warren Buffett and Michael Bloomberg, owner of Bloomberg LP, the parent company of Bloomberg News. Bloomberg and others told ProPublica they had paid the taxes they owed.\nTo remove advantages in the U.S. tax code that benefit the ultra-wealthy, Biden has proposed taxing inherited assets that currently escape levies, and boosting the top rate on investment income so that well-paid workers and investors pay the same.\nOn an international scale, the administration is seeking a global minimum tax of at least 15% for the world’s most profitable companies -- the deal expected to be pushed forward at the G-7 meeting this weekend.\nSponsored ContentThe New Auto RevolutionGAC Motor\nThe G-7 deal would change other rules for taxing multinationals, in order to undercut efforts to shift profits to low-tax countries. Biden is also advocating to increase the U.S. corporate rate to 28%, partly reversing Trump’s tax overhaul.\nRace to the Bottom\nWorldwide average statutory corporate income tax rates have been declining for four decades\nSource: Tax Foundation via Atlantic Council\nTech companies could see their effective tax rates jump if a global tax deal is reached, according to research from Morgan Stanley. Facebook and Alphabet’s Google could both pay 28% on their profits worldwide, up from 18% and 17% respectively under current rules, the report found.\nFor all the talk of taxing the rich, Biden’s proposals, and the international tax deal, face serious hurdles before they’re adopted.\nWhile some of his fellow Democrats, who narrowly control Congress, are pushing for more radical changes to the taxes of estates and wealth, others are hesitant.\nThe next step for the global tax negotiations, which were launched years ago by the Organization for Economic Cooperation and Development and have involved roughly 140 nations, is to win agreement among the Group of 20 countries. Finance ministers for the G-20, which collectively oversee about 90% of the world’s economy, will meet in July in Venice.\nStumbling blocks to reaching a deal by year-end include China, which may seekexemptionsfrom the minimum tax.\nStill, there are hopes the global effort “puts an end to the craziness,” said Pascal Saint-Amans, director of the center for tax policy at the OECD. “You had loopholes everywhere and nobody was taking care of that. It’s undermining the very goal of capitalism and a free-market economy.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183346512,"gmtCreate":1623311201636,"gmtModify":1704200609595,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183346512","repostId":"2142244006","repostType":4,"repost":{"id":"2142244006","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623310084,"share":"https://ttm.financial/m/news/2142244006?lang=&edition=fundamental","pubTime":"2021-06-10 15:28","market":"uk","language":"en","title":"ECB to keep money taps wide open even as recovery takes hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2142244006","media":"Reuters","summary":"FRANKFURT, June 10 (Reuters) - The European Central Bank is all but certain to maintain a generous f","content":"<p>FRANKFURT, June 10 (Reuters) - The European Central Bank is all but certain to maintain a generous flow of stimulus when policymakers meet on Thursday, fearing that higher borrowing costs could smother a still nascent recovery.</p>\n<p>Just emerging from a pandemic-induced double-dip recession, the 19-country euro zone economy has relied on unprecedented ECB stimulus to stay afloat. And even as growth surges with the easing of COVID-19 restrictions, policymakers appear keen to err on the side of caution.</p>\n<p>Recent comments from ECB President Christine Lagarde and board member Fabio Panetta suggest the June discussion effectively ended even before Thursday's meeting, with a cut in bond purchases unlikely, even if policymakers acknowledge an improvement in growth prospects and the rapid pace of vaccinations.</p>\n<p>Panetta flatly rejected any reduction in emergency bond buys while Lagarde said it was \"far too early\" to discuss tapering the bank's 1.85 trillion euro Pandemic Emergency Purchases Programme (PEPP).</p>\n<p>While policymakers could still opt for a different course, they usually line up behind their president and rarely make changes to proposals brought to the table by the six-member Executive Board.</p>\n<p>Weak medium-term inflation prospects are the key rationale for maintaining copious support but policymakers are also concerned that borrowing costs are inching up, so that any retreat by the ECB might risk setting off potentially dangerous market volatility.</p>\n<p>\"The longer the ECB waits before it admits that the rationale to run its Pandemic Emergency Purchase Programme at full speed is no longer as strong as it was in March, the less gentle could the transition to fewer asset purchases be in the future,\" Berenberg economist Holger Schmieding said.</p>\n<p>\"If so, bond yields could ratchet up more strongly after a while.\"</p>\n<p>Euro zone government bond yields were trading near their lowest levels since April on Thursday.</p>\n<p><b>SEPTEMBER</b></p>\n<p>Further complicating the picture, the ECB is likely to nudge up most if not all of its growth and inflation forecasts and could even upgrade its guidance on growth, declaring risks \"balanced\" to replace a long-standing line about downside risks.</p>\n<p>Inflation is also surging and last month exceeded the ECB's target of just under 2%, a mark it has undershot for most of the last decade.</p>\n<p>But the economy will need another year just to grow back to its pre-pandemic level and the inflation jump is mostly a reversal of last year's energy price plunge, not the start of a new era of price pressures, policymakers have said.</p>\n<p>Underlying price pressures, a key focus for the ECB, remain anaemic and wage growth is weak, pointing to excessively low inflation for years to come.</p>\n<p>Europe is also far behind the United States in its recovery so any withdrawal of support ahead of the Federal Reserve would be seen as a dangerous signal.</p>\n<p>U.S. inflation data, due to be published at 1230 GMT, is expected to show a 4.7% increase in prices last month, up from 4.2% in April, with a stronger reading likely to reignite speculation about fewer bond purchases from the Fed.</p>\n<p>Wholesale prices in both Japan and China rose at their fastest pace in over a decade due to surging commodity prices.</p>\n<p>\"Given the markets' nervousness about taper talk and the ECB's firm wish to distance itself from the taper preparations in the U.S. over the summer, the ECB is likely to signal unchanged purchases until September,\" Anatoli Annenkov, an economist at <a href=\"https://laohu8.com/S/SCGLF\">Societe Generale</a> said.</p>\n<p>But the end of the emergency buys is coming and policymakers are unlikely to enlarge the scheme or extend it beyond its scheduled end in March 2022, given the economy's solid rebound, economists polled by Reuters said.</p>\n<p>That will put pressure on policymakers to start plotting a course beyond the emergency bond buys. Some signals of that could come as soon as September, economists say.</p>\n<p>As medium-term inflation prospects remain muted, decreasing buying under PEPP is likely to be accompanied by an expansion of the ECB's less flexible but open-ended Asset Purchase Programme and signals that some ECB support, even if less generous, will continue well into the future.</p>\n<p>The ECB will announce its policy decision at 1145 GMT, followed by Lagarde's news conference at 1230 GMT. With Thursday's decision, the bank's deposit rate, its benchmark, will remain at minus 0.5%.</p>\n<p>(Reporting by Balazs Koranyi; Editing by Catherine Evans and Toby Chopra)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ECB to keep money taps wide open even as recovery takes hold</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nECB to keep money taps wide open even as recovery takes hold\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-10 15:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>FRANKFURT, June 10 (Reuters) - The European Central Bank is all but certain to maintain a generous flow of stimulus when policymakers meet on Thursday, fearing that higher borrowing costs could smother a still nascent recovery.</p>\n<p>Just emerging from a pandemic-induced double-dip recession, the 19-country euro zone economy has relied on unprecedented ECB stimulus to stay afloat. And even as growth surges with the easing of COVID-19 restrictions, policymakers appear keen to err on the side of caution.</p>\n<p>Recent comments from ECB President Christine Lagarde and board member Fabio Panetta suggest the June discussion effectively ended even before Thursday's meeting, with a cut in bond purchases unlikely, even if policymakers acknowledge an improvement in growth prospects and the rapid pace of vaccinations.</p>\n<p>Panetta flatly rejected any reduction in emergency bond buys while Lagarde said it was \"far too early\" to discuss tapering the bank's 1.85 trillion euro Pandemic Emergency Purchases Programme (PEPP).</p>\n<p>While policymakers could still opt for a different course, they usually line up behind their president and rarely make changes to proposals brought to the table by the six-member Executive Board.</p>\n<p>Weak medium-term inflation prospects are the key rationale for maintaining copious support but policymakers are also concerned that borrowing costs are inching up, so that any retreat by the ECB might risk setting off potentially dangerous market volatility.</p>\n<p>\"The longer the ECB waits before it admits that the rationale to run its Pandemic Emergency Purchase Programme at full speed is no longer as strong as it was in March, the less gentle could the transition to fewer asset purchases be in the future,\" Berenberg economist Holger Schmieding said.</p>\n<p>\"If so, bond yields could ratchet up more strongly after a while.\"</p>\n<p>Euro zone government bond yields were trading near their lowest levels since April on Thursday.</p>\n<p><b>SEPTEMBER</b></p>\n<p>Further complicating the picture, the ECB is likely to nudge up most if not all of its growth and inflation forecasts and could even upgrade its guidance on growth, declaring risks \"balanced\" to replace a long-standing line about downside risks.</p>\n<p>Inflation is also surging and last month exceeded the ECB's target of just under 2%, a mark it has undershot for most of the last decade.</p>\n<p>But the economy will need another year just to grow back to its pre-pandemic level and the inflation jump is mostly a reversal of last year's energy price plunge, not the start of a new era of price pressures, policymakers have said.</p>\n<p>Underlying price pressures, a key focus for the ECB, remain anaemic and wage growth is weak, pointing to excessively low inflation for years to come.</p>\n<p>Europe is also far behind the United States in its recovery so any withdrawal of support ahead of the Federal Reserve would be seen as a dangerous signal.</p>\n<p>U.S. inflation data, due to be published at 1230 GMT, is expected to show a 4.7% increase in prices last month, up from 4.2% in April, with a stronger reading likely to reignite speculation about fewer bond purchases from the Fed.</p>\n<p>Wholesale prices in both Japan and China rose at their fastest pace in over a decade due to surging commodity prices.</p>\n<p>\"Given the markets' nervousness about taper talk and the ECB's firm wish to distance itself from the taper preparations in the U.S. over the summer, the ECB is likely to signal unchanged purchases until September,\" Anatoli Annenkov, an economist at <a href=\"https://laohu8.com/S/SCGLF\">Societe Generale</a> said.</p>\n<p>But the end of the emergency buys is coming and policymakers are unlikely to enlarge the scheme or extend it beyond its scheduled end in March 2022, given the economy's solid rebound, economists polled by Reuters said.</p>\n<p>That will put pressure on policymakers to start plotting a course beyond the emergency bond buys. Some signals of that could come as soon as September, economists say.</p>\n<p>As medium-term inflation prospects remain muted, decreasing buying under PEPP is likely to be accompanied by an expansion of the ECB's less flexible but open-ended Asset Purchase Programme and signals that some ECB support, even if less generous, will continue well into the future.</p>\n<p>The ECB will announce its policy decision at 1145 GMT, followed by Lagarde's news conference at 1230 GMT. With Thursday's decision, the bank's deposit rate, its benchmark, will remain at minus 0.5%.</p>\n<p>(Reporting by Balazs Koranyi; Editing by Catherine Evans and Toby Chopra)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142244006","content_text":"FRANKFURT, June 10 (Reuters) - The European Central Bank is all but certain to maintain a generous flow of stimulus when policymakers meet on Thursday, fearing that higher borrowing costs could smother a still nascent recovery.\nJust emerging from a pandemic-induced double-dip recession, the 19-country euro zone economy has relied on unprecedented ECB stimulus to stay afloat. And even as growth surges with the easing of COVID-19 restrictions, policymakers appear keen to err on the side of caution.\nRecent comments from ECB President Christine Lagarde and board member Fabio Panetta suggest the June discussion effectively ended even before Thursday's meeting, with a cut in bond purchases unlikely, even if policymakers acknowledge an improvement in growth prospects and the rapid pace of vaccinations.\nPanetta flatly rejected any reduction in emergency bond buys while Lagarde said it was \"far too early\" to discuss tapering the bank's 1.85 trillion euro Pandemic Emergency Purchases Programme (PEPP).\nWhile policymakers could still opt for a different course, they usually line up behind their president and rarely make changes to proposals brought to the table by the six-member Executive Board.\nWeak medium-term inflation prospects are the key rationale for maintaining copious support but policymakers are also concerned that borrowing costs are inching up, so that any retreat by the ECB might risk setting off potentially dangerous market volatility.\n\"The longer the ECB waits before it admits that the rationale to run its Pandemic Emergency Purchase Programme at full speed is no longer as strong as it was in March, the less gentle could the transition to fewer asset purchases be in the future,\" Berenberg economist Holger Schmieding said.\n\"If so, bond yields could ratchet up more strongly after a while.\"\nEuro zone government bond yields were trading near their lowest levels since April on Thursday.\nSEPTEMBER\nFurther complicating the picture, the ECB is likely to nudge up most if not all of its growth and inflation forecasts and could even upgrade its guidance on growth, declaring risks \"balanced\" to replace a long-standing line about downside risks.\nInflation is also surging and last month exceeded the ECB's target of just under 2%, a mark it has undershot for most of the last decade.\nBut the economy will need another year just to grow back to its pre-pandemic level and the inflation jump is mostly a reversal of last year's energy price plunge, not the start of a new era of price pressures, policymakers have said.\nUnderlying price pressures, a key focus for the ECB, remain anaemic and wage growth is weak, pointing to excessively low inflation for years to come.\nEurope is also far behind the United States in its recovery so any withdrawal of support ahead of the Federal Reserve would be seen as a dangerous signal.\nU.S. inflation data, due to be published at 1230 GMT, is expected to show a 4.7% increase in prices last month, up from 4.2% in April, with a stronger reading likely to reignite speculation about fewer bond purchases from the Fed.\nWholesale prices in both Japan and China rose at their fastest pace in over a decade due to surging commodity prices.\n\"Given the markets' nervousness about taper talk and the ECB's firm wish to distance itself from the taper preparations in the U.S. over the summer, the ECB is likely to signal unchanged purchases until September,\" Anatoli Annenkov, an economist at Societe Generale said.\nBut the end of the emergency buys is coming and policymakers are unlikely to enlarge the scheme or extend it beyond its scheduled end in March 2022, given the economy's solid rebound, economists polled by Reuters said.\nThat will put pressure on policymakers to start plotting a course beyond the emergency bond buys. Some signals of that could come as soon as September, economists say.\nAs medium-term inflation prospects remain muted, decreasing buying under PEPP is likely to be accompanied by an expansion of the ECB's less flexible but open-ended Asset Purchase Programme and signals that some ECB support, even if less generous, will continue well into the future.\nThe ECB will announce its policy decision at 1145 GMT, followed by Lagarde's news conference at 1230 GMT. With Thursday's decision, the bank's deposit rate, its benchmark, will remain at minus 0.5%.\n(Reporting by Balazs Koranyi; Editing by Catherine Evans and Toby Chopra)","news_type":1},"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189813876,"gmtCreate":1623250697595,"gmtModify":1704199439409,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>gogogo","text":"$ContextLogic Inc.(WISH)$gogogo","images":[{"img":"https://static.tigerbbs.com/6091aeffbbd8fcfb948505af02f717db","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/189813876","isVote":1,"tweetType":1,"viewCount":487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":180956367,"gmtCreate":1623171571059,"gmtModify":1704197696900,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/UONE\">$Radio One(UONE)$</a>?","listText":"<a href=\"https://laohu8.com/S/UONE\">$Radio One(UONE)$</a>?","text":"$Radio One(UONE)$?","images":[{"img":"https://static.tigerbbs.com/601f8429dde8aea1b9dddc6cac99d943","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/180956367","isVote":1,"tweetType":1,"viewCount":162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":117776308,"gmtCreate":1623162662904,"gmtModify":1704197453700,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogogo","text":"$Skillz Inc(SKLZ)$gogogo","images":[{"img":"https://static.tigerbbs.com/4b3d17b1e1e777f505d100c96a927008","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117776308","isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":117051580,"gmtCreate":1623111153240,"gmtModify":1704196172430,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[{"img":"https://static.tigerbbs.com/798a19ab6f13eec45c911a67c89f5823","width":"1080","height":"2930"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117051580","isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":117029565,"gmtCreate":1623110817957,"gmtModify":1704196157359,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OEG\">$Orbital Energy Group(OEG)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/OEG\">$Orbital Energy Group(OEG)$</a>gogogo","text":"$Orbital Energy Group(OEG)$gogogo","images":[{"img":"https://static.tigerbbs.com/2dfe21dedb96b6f6d50d48a5c84c94ac","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117029565","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":114549971,"gmtCreate":1623081931293,"gmtModify":1704195774058,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Go","listText":"Go","text":"Go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114549971","repostId":"1108033863","repostType":4,"repost":{"id":"1108033863","pubTimestamp":1623087360,"share":"https://ttm.financial/m/news/1108033863?lang=&edition=fundamental","pubTime":"2021-06-08 01:36","market":"us","language":"en","title":"FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades","url":"https://stock-news.laohu8.com/highlight/detail?id=1108033863","media":"cnbc","summary":"(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer","content":"<div>\n<p>(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer's drug aducanumab, making it the first drug cleared by U.S. regulators to slow cognitive decline in...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 01:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer's drug aducanumab, making it the first drug cleared by U.S. regulators to slow cognitive decline in...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1108033863","content_text":"(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer's drug aducanumab, making it the first drug cleared by U.S. regulators to slow cognitive decline in people living with Alzheimer's and the first new medicine for the disease in nearly two decades.The FDA's decision was highly anticipated. The drug, which is marketed under the name Aduhelm, is also expected to generate billions of dollars in revenue for the company.\"We are well-aware of the attention surrounding this approval,\" Dr. Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, said in a press release. \"We understand that Aduhelm has garnered the attention of the press, the Alzheimer's patient community, our elected officials, and other interested stakeholders.\"\"With a treatment for a serious, life-threatening disease in the balance, it makes sense that so many people were following the outcome of this review,\" Cavazzoni added.Alzheimer’s disease is a progressive neurodegenerative disorder that slowly destroys memory and thinking skills. More than 6 million Americans are living with the disease, according toestimates by the Alzheimer’s Association.By 2050, that number is projected to rise to nearly 13 million, according to the group.There were previously no drugs cleared by the FDA that can slow the mental decline from Alzheimer’s, which is the sixth leading cause of death in the United States. The U.S. agency has approved Alzheimer’s drugs aimed at helping symptoms, not actually slowing the disease itself.Federal regulators have faced intense pressure from friends and family members of Alzheimer’s patients asking to fast-track aducanumab, but the road to regulatory approval has been a controversial one since it showed promise in 2016.In March of 2019, Biogen pulled work on the drug after an analysis from an independent group revealed it was unlikely to work. The company then shocked investors several months later by announcing it would seek regulatory approval for the drug after all.Shares of Biogen soared in Novemberafter it won backing from FDA staff, who said the company showed highly “persuasive” evidence aducanumab was effective and that it had “an acceptable safety profile that would support use in individuals with Alzheimer’s disease.”But two days later, a panel of outside experts that advises theU.S. agency unexpectedly declined to endorsethe experimental drug, citing unconvincing data. It also criticized agency staff for what it called an overly positive review.When Biogen sought approval for the drug in late 2019, its scientists said a new analysis of a larger data set showed that aducanumab “reduced clinical decline in patients with early Alzheimer’s disease.”Alzheimer’s experts and Wall Street analysts were immediately skeptical, with some wondering whether the clinical trial data was enough to prove that the drug works and whether approval could make it harder for other companies to enroll patients in their own drug trials.Some doctorshave said they won’t prescribethe drug if it does reach the market, because of the mixed data package supporting the company’s application.Supporters, including advocacy groups and family members of those living with the disease desperate for a new treatment, have acknowledged that the data isn’t perfect. However, they argue that it could help some patients with Alzheimer’s, a progressive and debilitating disease.Biogen’s drug targets a “sticky” compound in the brain known as beta-amyloid, which scientists expect plays a role in the devastating disease. The company has previously estimated about 1.5 million people with early Alzheimer’s in the U.S. could be candidates for the drug, according to Reuters.The FDA decision is expected to reverberate throughout the biopharma sector, RBC Capital Markets analyst Brian Abrahams said in a note to clients on June 1.The U.S. agency said Monday it determined there was “substantial evidence” the drug helps patients.“As a result of FDA’s approval of Aduhelm, patients with Alzheimer’s disease have an important and critical new treatment to help combat this disease,” it said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114540807,"gmtCreate":1623081887809,"gmtModify":1704195772926,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogo","listText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogo","text":"$Skillz Inc(SKLZ)$gogo","images":[{"img":"https://static.tigerbbs.com/71edab0c6e1807e11f235c676f0c3332","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114540807","isVote":1,"tweetType":1,"viewCount":178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":114557491,"gmtCreate":1623081845713,"gmtModify":1704195771473,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114557491","repostId":"2141127236","repostType":4,"isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114588198,"gmtCreate":1623079855114,"gmtModify":1704195722489,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogo","listText":"Gogo","text":"Gogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/114588198","repostId":"1133174841","repostType":4,"repost":{"id":"1133174841","pubTimestamp":1623078982,"share":"https://ttm.financial/m/news/1133174841?lang=&edition=fundamental","pubTime":"2021-06-07 23:16","market":"us","language":"en","title":"Palantir Is Sandbagging Growth Projections","url":"https://stock-news.laohu8.com/highlight/detail?id=1133174841","media":"seekingalpha","summary":"Summary\n\nFirst, I look at Palantir's price action this year.\nSecond, I examine PLTR's growth project","content":"<p><b>Summary</b></p>\n<ul>\n <li>First, I look at Palantir's price action this year.</li>\n <li>Second, I examine PLTR's growth projections.</li>\n <li>Third, I provide an overview of price-to-sales in PLTR's peer group.</li>\n <li>Lastly, I give my thoughts on price projections out through 2025.</li>\n</ul>\n<p>First, I look at Palantir's(NYSE:PLTR)price action this year. I provide some quick thoughts on what I've seen. Second, I look into PLTR's growth projections. I believe the aggression is hidden and I reveal why I feel that way. Third, I provide an overview of price-to-sales in PLTR's peer group, and what that means going forward, especially in light of revenue growth into 2025. Lastly, I revisit the topic of price but also price projections for investors.</p>\n<p><b>Rollercoaster</b></p>\n<p>Here's what's happened thus far in 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/8db04b39e358c9cdec5bc2d02251bd13\" tg-width=\"635\" tg-height=\"403\" referrerpolicy=\"no-referrer\">The summary is simple. We are back where we started in January. If you bought and then closed your eyes, you would have gone absolutely nowhere. And, if your eyes were wide open, you would have experienced rather significant volatility, bouncing up against $39 but also muddling through $18. It goes without saying that PLTR has moved 50% top to bottom. But, importantly, we are back where we started.</p>\n<p>Now, here's where it gets interesting, because just putting money into the NASDAQ (QQQ) would give you superior returns with far less stomach-churning volatility. I'm not concerned with owning QQQ. I'm more than happy to own PLTR because, as I'll show later, it's likely to 5x my investment from this point in time. In any case, take a look at the relative calm of QQQ.</p>\n<p><img src=\"https://static.tigerbbs.com/5563cce1afd961f1fe70a3ad7af88891\" tg-width=\"635\" tg-height=\"419\" referrerpolicy=\"no-referrer\">Here I want to add another layer of paint. We started with PLTR itself, then added QQQ. What happens when we go back in time to PLTR's direct listing?</p>\n<p><img src=\"https://static.tigerbbs.com/804f2c567c89bab14a62ee5b333631bb\" tg-width=\"635\" tg-height=\"419\" referrerpolicy=\"no-referrer\">This is the picture that matters most to me. Here's what this means in simple terms, which is what works best in my mind. If you bought early, nothing really happened for a few weeks but then PLTR really took off. Therefore, early investors -<i>like me</i>- took the risk and have benefitted greatly despite all volatility after the directly public offering. With a long view, volatility is not a threat or a \"risk\", but instead, it's an opportunity to buy low.</p>\n<p>In any case, if you started buying in 2021, then you're slightly behind versus the market but your investment certainly isn't trash. Furthermore, if you literally bought in the early part of 2021, and you held, then nothing bad has occurred. You are up. Again, volatility shakes out the weak hands. Long term, volatility is just noise - the price gets more and more smooth, year by year.</p>\n<p>Here's the insight. Buying and holding PLTR has worked out fine, even spectacularly, unless you bought during the big spikes in January, February, and March. Of course, if you traded against PLTR by shorting and buying puts during those times, you did fine. That's not my game, but I can see why it appeals to traders.</p>\n<p>Nevertheless, here's the key: For long-term buy-and-hold investors, PLTR is moving along just fine. Perhaps it's not winning like crazy in terms of price, but it's not exactly losing either. Our horizon is long and strong.</p>\n<p>There Is a Disturbance in the Force</p>\n<p>I'm rather surprised that there hasn't been more focus on PLTR's big picture projections. Specifically, I am talking about this:</p>\n<p><img src=\"https://static.tigerbbs.com/56383c3eaaea1d58abb1307e4fde30c6\" tg-width=\"640\" tg-height=\"362\" referrerpolicy=\"no-referrer\">Source:PLTR Q4 Business Update Presentation</p>\n<p>See the numbers there?<i>Revenue of $4 billion or more in 2025</i>.</p>\n<p>We also know that PLTR grew Q1 2021 revenue by49% year-over-year, generating $341 million across government and commercial segments. That's above the 45% revenue growth previously projected. That's a run rate of $800 million for 2021. And, for Q2 2021, revenue growth is expected to be 43%, which translates to $360 million.</p>\n<p>Those numbers for 2021 are fine and dandy and useful to hear. However, what I like more is that PLTR expects 30% growth in 2021 and the next four years. Yes, there's an implication of growth slowing in H2 of 2021, I see that too. However, we can run some pretty simple calculus with these numbers.</p>\n<p>First, we can start with the $800 million projection for 2021, check it against the 30% growth expectations. Here's how it lines up.</p>\n<ul>\n <li>2021 = $800 million</li>\n <li>2022 = $1,040 million (30% growth)</li>\n <li>2023 = $1,350 million (30% growth)</li>\n <li>2024 = $1,760 million (30% growth)</li>\n <li>2025 = $2,300 million (30% growth)</li>\n</ul>\n<p>In other words, when we start with $800 million for 2021, it's pretty obvious that the 30% growth doesn't cut it. We cannot reach $4 billion by 2025 with \"only\" 30% growth. PLTR is perhapssandbaggingto keep expectations lower. It's hard to know for sure. It could also be that they expect faster growth in 2022 through 2025. Let's run these numbers again with 40% growth.</p>\n<ul>\n <li>2021 = $800 million</li>\n <li>2022 = $1,120 million (40% growth)</li>\n <li>2023 = $1,570 million (40% growth)</li>\n <li>2024 = $2,195 million (40% growth)</li>\n <li>2025 = $3,070 million (40% growth)</li>\n</ul>\n<p>Once again, even with 40% year-over-year growth, we do not reach the $4 billion projected for 2025. Now, here's the first thing I want to point out about this oddity. My numbers might be wrong. My math might be too simple. I understand that possibility, but what this tells me is that PLTR has a different view of growth than my \"straight line\" projections. They are predators, but they are cautious too.</p>\n<p>What happens if we go a little crazy and use 49%, which is what PLTR achieved in Q1 2021. That's nearly 50% growth, of course. Here's how it looks using the same approach I've been using above.</p>\n<ul>\n <li>2021 = $800 million</li>\n <li>2022 = $1,200 million (49% growth)</li>\n <li>2023 = $1,776 million (49% growth)</li>\n <li>2024 = $2,246 million (49% growth)</li>\n <li>2025 = $3,943 million (49% growth)</li>\n</ul>\n<p>Hopefully, now it's clear why I'm so surprised that this hasn't been given more attention. While I realize I'm using \"straight line\" projections year-over-year, I'm kind of shocked that these assumptions and projections haven't been better analyzed until now. The numbers are obvious and simple, and coming straight from PLTR.</p>\n<p>Again, maybe I've got something wrong here, but to achieve $4 billion in revenue in 2025,<i>PLTR is going to have to grow by 50% every year</i>, from 2022 through 2025. That's an empirical necessity. Therefore, either PLTR is dead wrong and cannot achieve $4 billion in revenue, or perhaps they expect growth to be 50% year-over-year, or maybe that growth will be 40%, then 50%, then even higher. That is, they expect growth to accelerate.</p>\n<p>I don't believe that PLTR would knowingly publish expectations of $4 billion in 2025 without strong conviction. That is to say, it doesn't appear to be aspirational given their relatively cautious and conservative leadership. After all, theywaited 17 years to go public. Plus, with their load of government customers, it's not like they can fly by the seat of their pants. It is not in their DNA or the culture of the business from what I've seen.</p>\n<p>Peers and Price</p>\n<p>Here we take an interesting turn. Although I've written about PLTR many times, I haven't revealed something publicly before. Specifically, I have direct experience with a defense contractor. To be even more precise, I worked inside a defense contractor in a privileged position with access to an amazing crew of programmers, engineers, and technicians. That experience gave me a direct, hands-on, real-world view of how government contracting works, how the government embraces technology, and how the pieces and parts are all stitched together. I'll stop short at this point; I can't provide more details.</p>\n<p>What I can tell you is that my previous work experience has helped me take a long view on PLTR. To wit, I bought PLTR early and I haven't sold a single share. Furthermore, as you might know already, I've boughtPLTR LEAPS.</p>\n<p>Additionally, I've had several people reach out to me 1-to-1 about PLTR, including their experiences and their views. During one of these exchanges, a high ranking official and I came to agree on PLTR's peer group. I'm certainly not talking about true competitors here. I'm very specifically talking about reasonable<i>comparisons</i>for the sake of valuation. I'm talking about the general vibe of data analytics at enterprise scale, user behavior analytics, data frameworks, and so on, and so forth. Here's the list:</p>\n<ul>\n <li>Snowflake (SNOW)</li>\n <li>Alteryx (AYX)</li>\n <li>Datadog (DDOG)</li>\n <li>Salesforce (CRM)</li>\n <li>Splunk (SPLK)</li>\n</ul>\n<p>It's not necessary to agree on all of these. Instead, these are merely a reasonable cluster of companies that have similar characteristics to PLTR, although I would offer that<i>none of them would be a true direct peer</i>. I do not see even a single company that is as rich and robust as PLTR, nevertheless, we need something of a \"peer group\" to move forward.</p>\n<p>Now, with this in mind, here's how we'll proceed. Since PLTR is so newly listed and it's relatively young on the public market, I will keep things simple. I'm very interested in earnings and profits, of course, but here I want to simply compare PLTR on the basis of sales. Therefore, I feel it's somewhat rational to compare PLTR using price-to-sales. Here's how PLTR stacks up.</p>\n<p><img src=\"https://static.tigerbbs.com/c77f9e680346dc75cdad7e6073ba1c40\" tg-width=\"635\" tg-height=\"487\">Being really simple here, PLTR gets just 30-35% the P/S of SNOW. However, it gets triple that of CRM. That's quite a spread. Then again, SNOW is expecting 120% revenue growth in 2021 and86% in 2022. Right now, on the high end, SNOW has the growth edge. I am unclear about how that growth plays out into 2023, 2024, and 2025. I suspect the law of large numbers will kick in, and growth will slow. We'll see. Meanwhile, CRM is a large yet fast-growing company, clocking in with an impressive24% year-over-year revenue gain.</p>\n<p>I believe that SNOW's high growth rate will fall, as I hinted at above. Perhaps down into the 50-60% range over the next few years. We'll see. And, I believe that CRM will likely maintain a 22-25% growth rate. However, per PLTR's projections of $4 billion, I see growth above 30%. In fact, I see compound annual growth at 45-50%.</p>\n<p>In a funny way, all that doesn't even matter much. That's because the story I see is that PLTR doesn't need to massively grow beyond what we're already seeing. If we merely assume that PLTR can basically hang on to the growth it's getting right now - without any slowdown or acceleration - we can do some fun back-of-the-napkin math. The P/S ratios give us an indication that PLTR is trading at a price that is about right given its peers at this point in time. I'm not interested in SNOW vs. PLTR, or CRM vs. PLTR. I'm merely pointing out that PLTR's P/S is relatively rational given its growth. We can pivot a bit now.</p>\n<p>Here's another picture in my mind. If you take CRM and AYX, for example, both of which have a longer history than SNOW or PLTR, you can see that growing revenues translate to strongly growing stock prices. Furthermore, and more importantly, price growth roughly stays around revenue growth. Clearly, it's not perfect, but it sure looks highly correlated to me; 400% growth in AYX, and 150% growth in CRM. Timing matters here, of course, but the general trends here are telling.</p>\n<p><img src=\"https://static.tigerbbs.com/20e55c201426815f58f411103f705b88\" tg-width=\"635\" tg-height=\"453\">This makes me feel comfortable making some broad generalizations. I'm going to give year-by-year price ranges for PLTR given 30-50% growth rates. This is supported by what I've seen in PLTR's peer group, whereby P/S makes sense given growth rates, and the revenue growth vs. share price growth seems to mirror each other fairly well. I'm not trying to be exactly right here. I'm looking for potentiality, given publicly available information.</p>\n<ul>\n <li>Today = $24</li>\n <li>2022 = $31 (30% growth)</li>\n <li>2023 = $41 (30% growth)</li>\n <li>2024 = $52 (30% growth)</li>\n <li>2025 = $69 (30% growth)</li>\n</ul>\n<p>Now, let's juice the growth to 40%.</p>\n<ul>\n <li>Today = $24</li>\n <li>2022 = $34 (40% growth)</li>\n <li>2023 = $47 (40% growth)</li>\n <li>2024 = $66 (40% growth)</li>\n <li>2025 = $92 (40% growth)</li>\n</ul>\n<p>I still don't think that's accurate per my discussion up above. To achieve $4 billion in revenue, PLTR needs to hit about 50% growth every year. I'm going \"straight line\" again, with no assumptions about increasing or decreasing growth along the way. Again, I'm keeping this simple and easy. Here's how the price looks at that level of growth:</p>\n<ul>\n <li>Today = $24</li>\n <li>2022 = $36 (50% growth)</li>\n <li>2023 = $54 (50% growth)</li>\n <li>2024 = $81 (50% growth)</li>\n <li>2025 = $122 (50% growth)</li>\n</ul>\n<p><b>Perspective Is Everything</b></p>\n<p>Clearly, it's possible to be happy or sad about PLTR's price depending on when you bought. It would be understandable to be frustrated with PLTR if you bought around in the $35-45 range. On the other hand, if you bought down around $10-15, then you're probably feeling just fine. This isn't just how it works with PLTR, of course. Nevertheless, it's a healthy reminder.</p>\n<p>In the past, I've said I believe that PLTR will hit $75 by 2023. Even my relatively aggressive numbers above with 50% growth do not hit $75 in 2023, and in fact, I'm seeing $54 in 2023. However, here's the critical point. I still believe that PLTR is likely to hit $70-75 in 2023. I don't expect it to hold that price for long, but I do think because it's a growth company and because news and contacts are \"lumpy\" that we'll see spikes into the $70-75 range. Yet, since I don't trade, I'm fine sticking with my $50-55 normalized target. After all, I'm still doubling my money from this point. And it'll actually be about 5x my original investment in 2023 and 8-10x by 2025. I'm looking ahead about 3-4 years, and I'm seeing a 10-bagger for myself, given my cost basis. For most investors, PLTR appears to be an easy hold, and in fact, I think at $22-25, PLTR is a rational buy right now. I'd be far less interested in buying if the price spiked to $35 or above unless I was trading short-term options.</p>\n<p>And finally, what I'm seeing indicates that<i>PLTR is sandbagging on growth</i>, otherwise, its $4 billion in 2023 would have been revised downward. Therefore, given that large revenue target, I think it's safe to assume that PLTR actually must expect 45-50% growth, not the lower projection of 30%+ revenue growth as they have indicated in theQ4 2020andQ1 2021Earnings Call presentations. In short, I place my bets on more growth, not less. If that's true, the price will easily hold. Or, more likely, the price moves upward more aggressively over the coming years.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Is Sandbagging Growth Projections</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Is Sandbagging Growth Projections\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-07 23:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4433292-palantir-sandbagging-growth-projections><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nFirst, I look at Palantir's price action this year.\nSecond, I examine PLTR's growth projections.\nThird, I provide an overview of price-to-sales in PLTR's peer group.\nLastly, I give my ...</p>\n\n<a href=\"https://seekingalpha.com/article/4433292-palantir-sandbagging-growth-projections\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://seekingalpha.com/article/4433292-palantir-sandbagging-growth-projections","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1133174841","content_text":"Summary\n\nFirst, I look at Palantir's price action this year.\nSecond, I examine PLTR's growth projections.\nThird, I provide an overview of price-to-sales in PLTR's peer group.\nLastly, I give my thoughts on price projections out through 2025.\n\nFirst, I look at Palantir's(NYSE:PLTR)price action this year. I provide some quick thoughts on what I've seen. Second, I look into PLTR's growth projections. I believe the aggression is hidden and I reveal why I feel that way. Third, I provide an overview of price-to-sales in PLTR's peer group, and what that means going forward, especially in light of revenue growth into 2025. Lastly, I revisit the topic of price but also price projections for investors.\nRollercoaster\nHere's what's happened thus far in 2021.\nThe summary is simple. We are back where we started in January. If you bought and then closed your eyes, you would have gone absolutely nowhere. And, if your eyes were wide open, you would have experienced rather significant volatility, bouncing up against $39 but also muddling through $18. It goes without saying that PLTR has moved 50% top to bottom. But, importantly, we are back where we started.\nNow, here's where it gets interesting, because just putting money into the NASDAQ (QQQ) would give you superior returns with far less stomach-churning volatility. I'm not concerned with owning QQQ. I'm more than happy to own PLTR because, as I'll show later, it's likely to 5x my investment from this point in time. In any case, take a look at the relative calm of QQQ.\nHere I want to add another layer of paint. We started with PLTR itself, then added QQQ. What happens when we go back in time to PLTR's direct listing?\nThis is the picture that matters most to me. Here's what this means in simple terms, which is what works best in my mind. If you bought early, nothing really happened for a few weeks but then PLTR really took off. Therefore, early investors -like me- took the risk and have benefitted greatly despite all volatility after the directly public offering. With a long view, volatility is not a threat or a \"risk\", but instead, it's an opportunity to buy low.\nIn any case, if you started buying in 2021, then you're slightly behind versus the market but your investment certainly isn't trash. Furthermore, if you literally bought in the early part of 2021, and you held, then nothing bad has occurred. You are up. Again, volatility shakes out the weak hands. Long term, volatility is just noise - the price gets more and more smooth, year by year.\nHere's the insight. Buying and holding PLTR has worked out fine, even spectacularly, unless you bought during the big spikes in January, February, and March. Of course, if you traded against PLTR by shorting and buying puts during those times, you did fine. That's not my game, but I can see why it appeals to traders.\nNevertheless, here's the key: For long-term buy-and-hold investors, PLTR is moving along just fine. Perhaps it's not winning like crazy in terms of price, but it's not exactly losing either. Our horizon is long and strong.\nThere Is a Disturbance in the Force\nI'm rather surprised that there hasn't been more focus on PLTR's big picture projections. Specifically, I am talking about this:\nSource:PLTR Q4 Business Update Presentation\nSee the numbers there?Revenue of $4 billion or more in 2025.\nWe also know that PLTR grew Q1 2021 revenue by49% year-over-year, generating $341 million across government and commercial segments. That's above the 45% revenue growth previously projected. That's a run rate of $800 million for 2021. And, for Q2 2021, revenue growth is expected to be 43%, which translates to $360 million.\nThose numbers for 2021 are fine and dandy and useful to hear. However, what I like more is that PLTR expects 30% growth in 2021 and the next four years. Yes, there's an implication of growth slowing in H2 of 2021, I see that too. However, we can run some pretty simple calculus with these numbers.\nFirst, we can start with the $800 million projection for 2021, check it against the 30% growth expectations. Here's how it lines up.\n\n2021 = $800 million\n2022 = $1,040 million (30% growth)\n2023 = $1,350 million (30% growth)\n2024 = $1,760 million (30% growth)\n2025 = $2,300 million (30% growth)\n\nIn other words, when we start with $800 million for 2021, it's pretty obvious that the 30% growth doesn't cut it. We cannot reach $4 billion by 2025 with \"only\" 30% growth. PLTR is perhapssandbaggingto keep expectations lower. It's hard to know for sure. It could also be that they expect faster growth in 2022 through 2025. Let's run these numbers again with 40% growth.\n\n2021 = $800 million\n2022 = $1,120 million (40% growth)\n2023 = $1,570 million (40% growth)\n2024 = $2,195 million (40% growth)\n2025 = $3,070 million (40% growth)\n\nOnce again, even with 40% year-over-year growth, we do not reach the $4 billion projected for 2025. Now, here's the first thing I want to point out about this oddity. My numbers might be wrong. My math might be too simple. I understand that possibility, but what this tells me is that PLTR has a different view of growth than my \"straight line\" projections. They are predators, but they are cautious too.\nWhat happens if we go a little crazy and use 49%, which is what PLTR achieved in Q1 2021. That's nearly 50% growth, of course. Here's how it looks using the same approach I've been using above.\n\n2021 = $800 million\n2022 = $1,200 million (49% growth)\n2023 = $1,776 million (49% growth)\n2024 = $2,246 million (49% growth)\n2025 = $3,943 million (49% growth)\n\nHopefully, now it's clear why I'm so surprised that this hasn't been given more attention. While I realize I'm using \"straight line\" projections year-over-year, I'm kind of shocked that these assumptions and projections haven't been better analyzed until now. The numbers are obvious and simple, and coming straight from PLTR.\nAgain, maybe I've got something wrong here, but to achieve $4 billion in revenue in 2025,PLTR is going to have to grow by 50% every year, from 2022 through 2025. That's an empirical necessity. Therefore, either PLTR is dead wrong and cannot achieve $4 billion in revenue, or perhaps they expect growth to be 50% year-over-year, or maybe that growth will be 40%, then 50%, then even higher. That is, they expect growth to accelerate.\nI don't believe that PLTR would knowingly publish expectations of $4 billion in 2025 without strong conviction. That is to say, it doesn't appear to be aspirational given their relatively cautious and conservative leadership. After all, theywaited 17 years to go public. Plus, with their load of government customers, it's not like they can fly by the seat of their pants. It is not in their DNA or the culture of the business from what I've seen.\nPeers and Price\nHere we take an interesting turn. Although I've written about PLTR many times, I haven't revealed something publicly before. Specifically, I have direct experience with a defense contractor. To be even more precise, I worked inside a defense contractor in a privileged position with access to an amazing crew of programmers, engineers, and technicians. That experience gave me a direct, hands-on, real-world view of how government contracting works, how the government embraces technology, and how the pieces and parts are all stitched together. I'll stop short at this point; I can't provide more details.\nWhat I can tell you is that my previous work experience has helped me take a long view on PLTR. To wit, I bought PLTR early and I haven't sold a single share. Furthermore, as you might know already, I've boughtPLTR LEAPS.\nAdditionally, I've had several people reach out to me 1-to-1 about PLTR, including their experiences and their views. During one of these exchanges, a high ranking official and I came to agree on PLTR's peer group. I'm certainly not talking about true competitors here. I'm very specifically talking about reasonablecomparisonsfor the sake of valuation. I'm talking about the general vibe of data analytics at enterprise scale, user behavior analytics, data frameworks, and so on, and so forth. Here's the list:\n\nSnowflake (SNOW)\nAlteryx (AYX)\nDatadog (DDOG)\nSalesforce (CRM)\nSplunk (SPLK)\n\nIt's not necessary to agree on all of these. Instead, these are merely a reasonable cluster of companies that have similar characteristics to PLTR, although I would offer thatnone of them would be a true direct peer. I do not see even a single company that is as rich and robust as PLTR, nevertheless, we need something of a \"peer group\" to move forward.\nNow, with this in mind, here's how we'll proceed. Since PLTR is so newly listed and it's relatively young on the public market, I will keep things simple. I'm very interested in earnings and profits, of course, but here I want to simply compare PLTR on the basis of sales. Therefore, I feel it's somewhat rational to compare PLTR using price-to-sales. Here's how PLTR stacks up.\nBeing really simple here, PLTR gets just 30-35% the P/S of SNOW. However, it gets triple that of CRM. That's quite a spread. Then again, SNOW is expecting 120% revenue growth in 2021 and86% in 2022. Right now, on the high end, SNOW has the growth edge. I am unclear about how that growth plays out into 2023, 2024, and 2025. I suspect the law of large numbers will kick in, and growth will slow. We'll see. Meanwhile, CRM is a large yet fast-growing company, clocking in with an impressive24% year-over-year revenue gain.\nI believe that SNOW's high growth rate will fall, as I hinted at above. Perhaps down into the 50-60% range over the next few years. We'll see. And, I believe that CRM will likely maintain a 22-25% growth rate. However, per PLTR's projections of $4 billion, I see growth above 30%. In fact, I see compound annual growth at 45-50%.\nIn a funny way, all that doesn't even matter much. That's because the story I see is that PLTR doesn't need to massively grow beyond what we're already seeing. If we merely assume that PLTR can basically hang on to the growth it's getting right now - without any slowdown or acceleration - we can do some fun back-of-the-napkin math. The P/S ratios give us an indication that PLTR is trading at a price that is about right given its peers at this point in time. I'm not interested in SNOW vs. PLTR, or CRM vs. PLTR. I'm merely pointing out that PLTR's P/S is relatively rational given its growth. We can pivot a bit now.\nHere's another picture in my mind. If you take CRM and AYX, for example, both of which have a longer history than SNOW or PLTR, you can see that growing revenues translate to strongly growing stock prices. Furthermore, and more importantly, price growth roughly stays around revenue growth. Clearly, it's not perfect, but it sure looks highly correlated to me; 400% growth in AYX, and 150% growth in CRM. Timing matters here, of course, but the general trends here are telling.\nThis makes me feel comfortable making some broad generalizations. I'm going to give year-by-year price ranges for PLTR given 30-50% growth rates. This is supported by what I've seen in PLTR's peer group, whereby P/S makes sense given growth rates, and the revenue growth vs. share price growth seems to mirror each other fairly well. I'm not trying to be exactly right here. I'm looking for potentiality, given publicly available information.\n\nToday = $24\n2022 = $31 (30% growth)\n2023 = $41 (30% growth)\n2024 = $52 (30% growth)\n2025 = $69 (30% growth)\n\nNow, let's juice the growth to 40%.\n\nToday = $24\n2022 = $34 (40% growth)\n2023 = $47 (40% growth)\n2024 = $66 (40% growth)\n2025 = $92 (40% growth)\n\nI still don't think that's accurate per my discussion up above. To achieve $4 billion in revenue, PLTR needs to hit about 50% growth every year. I'm going \"straight line\" again, with no assumptions about increasing or decreasing growth along the way. Again, I'm keeping this simple and easy. Here's how the price looks at that level of growth:\n\nToday = $24\n2022 = $36 (50% growth)\n2023 = $54 (50% growth)\n2024 = $81 (50% growth)\n2025 = $122 (50% growth)\n\nPerspective Is Everything\nClearly, it's possible to be happy or sad about PLTR's price depending on when you bought. It would be understandable to be frustrated with PLTR if you bought around in the $35-45 range. On the other hand, if you bought down around $10-15, then you're probably feeling just fine. This isn't just how it works with PLTR, of course. Nevertheless, it's a healthy reminder.\nIn the past, I've said I believe that PLTR will hit $75 by 2023. Even my relatively aggressive numbers above with 50% growth do not hit $75 in 2023, and in fact, I'm seeing $54 in 2023. However, here's the critical point. I still believe that PLTR is likely to hit $70-75 in 2023. I don't expect it to hold that price for long, but I do think because it's a growth company and because news and contacts are \"lumpy\" that we'll see spikes into the $70-75 range. Yet, since I don't trade, I'm fine sticking with my $50-55 normalized target. After all, I'm still doubling my money from this point. And it'll actually be about 5x my original investment in 2023 and 8-10x by 2025. I'm looking ahead about 3-4 years, and I'm seeing a 10-bagger for myself, given my cost basis. For most investors, PLTR appears to be an easy hold, and in fact, I think at $22-25, PLTR is a rational buy right now. I'd be far less interested in buying if the price spiked to $35 or above unless I was trading short-term options.\nAnd finally, what I'm seeing indicates thatPLTR is sandbagging on growth, otherwise, its $4 billion in 2023 would have been revised downward. Therefore, given that large revenue target, I think it's safe to assume that PLTR actually must expect 45-50% growth, not the lower projection of 30%+ revenue growth as they have indicated in theQ4 2020andQ1 2021Earnings Call presentations. In short, I place my bets on more growth, not less. If that's true, the price will easily hold. Or, more likely, the price moves upward more aggressively over the coming years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":27,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114256244,"gmtCreate":1623076734988,"gmtModify":1704195626142,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogogo","text":"$Skillz Inc(SKLZ)$gogogo","images":[{"img":"https://static.tigerbbs.com/643055b717fd2a0e305c56043dc126d5","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114256244","isVote":1,"tweetType":1,"viewCount":67,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":112921359,"gmtCreate":1622847409471,"gmtModify":1704192207094,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SKYT\">$SkyWater Technology, Inc.(SKYT)$</a>&nbsp;small start","listText":"<a href=\"https://laohu8.com/S/SKYT\">$SkyWater Technology, Inc.(SKYT)$</a>&nbsp;small start","text":"$SkyWater Technology, Inc.(SKYT)$ small start","images":[{"img":"https://static.tigerbbs.com/825dc2a3f00f4f22dc54d98736a39a21","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/112921359","isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":112062897,"gmtCreate":1622826044519,"gmtModify":1704192065606,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>&nbsp;finally green","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>&nbsp;finally green","text":"$Microvision(MVIS)$ finally green","images":[{"img":"https://static.tigerbbs.com/c1afa9547683014fdbdb770aa2b1170b","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/112062897","isVote":1,"tweetType":1,"viewCount":187,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":134188427,"gmtCreate":1622211390569,"gmtModify":1704181616242,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>?","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>?","text":"$Tiger Brokers(TIGR)$?","images":[{"img":"https://static.tigerbbs.com/43632d82ad61cb7886cbadd8f531bd28","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/134188427","isVote":1,"tweetType":1,"viewCount":120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":378625153,"gmtCreate":1619026051972,"gmtModify":1704718541583,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GLSI\">$Greenwich Lifesciences Inc(GLSI)$</a>good prospective","listText":"<a href=\"https://laohu8.com/S/GLSI\">$Greenwich Lifesciences Inc(GLSI)$</a>good prospective","text":"$Greenwich Lifesciences Inc(GLSI)$good prospective","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/378625153","isVote":1,"tweetType":1,"viewCount":232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":370068988,"gmtCreate":1618536952944,"gmtModify":1704712367055,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Diamond hand","listText":"Diamond hand","text":"Diamond hand","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/370068988","repostId":"1104323307","repostType":4,"repost":{"id":"1104323307","pubTimestamp":1618534802,"share":"https://ttm.financial/m/news/1104323307?lang=&edition=fundamental","pubTime":"2021-04-16 09:00","market":"us","language":"en","title":"Why Zomedica Stock Plunged Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1104323307","media":"Motley Fool","summary":"Initial sales of a key product may be lower than investors were hoping for.\nWhat happened\nShares of ","content":"<p>Initial sales of a key product may be lower than investors were hoping for.</p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Zomedica Pharmaceuticals</b>&nbsp;(NYSEMKT:ZOM)&nbsp;fell 13.7% on Thursday after the veterinary health company announced a change to its sales strategy.</p>\n<p><b>So what</b></p>\n<p>Zomedica will build out its internal sales team as it transitions away from its current distributor-based approach. CEO Robert Cohen said the move was precipitated by \"changes at our current distributor that we believe have impacted its ability to market our products effectively.\" Those words likely startled investors, many of whom decided to&nbsp;sell&nbsp;their shares.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2801a170fd507ea28b362a0630d8590b\" tg-width=\"2000\" tg-height=\"1232\"><span>ZOMEDICA'S STOCK PRICE DROPPED SHARPLY ON THURSDAY. IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p>To be fair, Cohen said that while the shift might negatively impact near-term sales of its Truforma diagnostic platform for dogs and cats, it could have some long-term benefits.</p>\n<p>\"While this effort may slow initial sales of Truforma, we have taken this action now to avoid any disruption to our customers and to provide a stronger foundation on which to build the marketing and sales of both Truforma&nbsp;and any future products developed or acquired by Zomedica,\" Cohen said in a press release.</p>\n<p><b>Now what</b></p>\n<p>Zomedica recorded its first veterinarian sale of Truforma in mid-March. The diagnostic platform lies at the core of the company's commercial strategy and is likely to remain its only revenue generator for some time. Investors, in turn, are understandably concerned about a potential slower sales rollout for Truforma.</p>\n<p>That said, Zomedica raised roughly $200 million via a share offering in February, so it has the cash it needs to ramp up its sales team. Shareholders will need to be patient with Zomedica's new approach, but if Truforma is the game changer management says it is, then sales should eventually materialize.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Zomedica Stock Plunged Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Zomedica Stock Plunged Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-16 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/15/why-zomedica-stock-plunged-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Initial sales of a key product may be lower than investors were hoping for.\nWhat happened\nShares of Zomedica Pharmaceuticals (NYSEMKT:ZOM) fell 13.7% on Thursday after the veterinary health company ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/15/why-zomedica-stock-plunged-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZOM":"Zomedica Pharmaceuticals Corp."},"source_url":"https://www.fool.com/investing/2021/04/15/why-zomedica-stock-plunged-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104323307","content_text":"Initial sales of a key product may be lower than investors were hoping for.\nWhat happened\nShares of Zomedica Pharmaceuticals (NYSEMKT:ZOM) fell 13.7% on Thursday after the veterinary health company announced a change to its sales strategy.\nSo what\nZomedica will build out its internal sales team as it transitions away from its current distributor-based approach. CEO Robert Cohen said the move was precipitated by \"changes at our current distributor that we believe have impacted its ability to market our products effectively.\" Those words likely startled investors, many of whom decided to sell their shares.\nZOMEDICA'S STOCK PRICE DROPPED SHARPLY ON THURSDAY. IMAGE SOURCE: GETTY IMAGES.\nTo be fair, Cohen said that while the shift might negatively impact near-term sales of its Truforma diagnostic platform for dogs and cats, it could have some long-term benefits.\n\"While this effort may slow initial sales of Truforma, we have taken this action now to avoid any disruption to our customers and to provide a stronger foundation on which to build the marketing and sales of both Truforma and any future products developed or acquired by Zomedica,\" Cohen said in a press release.\nNow what\nZomedica recorded its first veterinarian sale of Truforma in mid-March. The diagnostic platform lies at the core of the company's commercial strategy and is likely to remain its only revenue generator for some time. Investors, in turn, are understandably concerned about a potential slower sales rollout for Truforma.\nThat said, Zomedica raised roughly $200 million via a share offering in February, so it has the cash it needs to ramp up its sales team. Shareholders will need to be patient with Zomedica's new approach, but if Truforma is the game changer management says it is, then sales should eventually materialize.","news_type":1},"isVote":1,"tweetType":1,"viewCount":107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":114588198,"gmtCreate":1623079855114,"gmtModify":1704195722489,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogo","listText":"Gogo","text":"Gogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/114588198","repostId":"1133174841","repostType":4,"repost":{"id":"1133174841","pubTimestamp":1623078982,"share":"https://ttm.financial/m/news/1133174841?lang=&edition=fundamental","pubTime":"2021-06-07 23:16","market":"us","language":"en","title":"Palantir Is Sandbagging Growth Projections","url":"https://stock-news.laohu8.com/highlight/detail?id=1133174841","media":"seekingalpha","summary":"Summary\n\nFirst, I look at Palantir's price action this year.\nSecond, I examine PLTR's growth project","content":"<p><b>Summary</b></p>\n<ul>\n <li>First, I look at Palantir's price action this year.</li>\n <li>Second, I examine PLTR's growth projections.</li>\n <li>Third, I provide an overview of price-to-sales in PLTR's peer group.</li>\n <li>Lastly, I give my thoughts on price projections out through 2025.</li>\n</ul>\n<p>First, I look at Palantir's(NYSE:PLTR)price action this year. I provide some quick thoughts on what I've seen. Second, I look into PLTR's growth projections. I believe the aggression is hidden and I reveal why I feel that way. Third, I provide an overview of price-to-sales in PLTR's peer group, and what that means going forward, especially in light of revenue growth into 2025. Lastly, I revisit the topic of price but also price projections for investors.</p>\n<p><b>Rollercoaster</b></p>\n<p>Here's what's happened thus far in 2021.</p>\n<p><img src=\"https://static.tigerbbs.com/8db04b39e358c9cdec5bc2d02251bd13\" tg-width=\"635\" tg-height=\"403\" referrerpolicy=\"no-referrer\">The summary is simple. We are back where we started in January. If you bought and then closed your eyes, you would have gone absolutely nowhere. And, if your eyes were wide open, you would have experienced rather significant volatility, bouncing up against $39 but also muddling through $18. It goes without saying that PLTR has moved 50% top to bottom. But, importantly, we are back where we started.</p>\n<p>Now, here's where it gets interesting, because just putting money into the NASDAQ (QQQ) would give you superior returns with far less stomach-churning volatility. I'm not concerned with owning QQQ. I'm more than happy to own PLTR because, as I'll show later, it's likely to 5x my investment from this point in time. In any case, take a look at the relative calm of QQQ.</p>\n<p><img src=\"https://static.tigerbbs.com/5563cce1afd961f1fe70a3ad7af88891\" tg-width=\"635\" tg-height=\"419\" referrerpolicy=\"no-referrer\">Here I want to add another layer of paint. We started with PLTR itself, then added QQQ. What happens when we go back in time to PLTR's direct listing?</p>\n<p><img src=\"https://static.tigerbbs.com/804f2c567c89bab14a62ee5b333631bb\" tg-width=\"635\" tg-height=\"419\" referrerpolicy=\"no-referrer\">This is the picture that matters most to me. Here's what this means in simple terms, which is what works best in my mind. If you bought early, nothing really happened for a few weeks but then PLTR really took off. Therefore, early investors -<i>like me</i>- took the risk and have benefitted greatly despite all volatility after the directly public offering. With a long view, volatility is not a threat or a \"risk\", but instead, it's an opportunity to buy low.</p>\n<p>In any case, if you started buying in 2021, then you're slightly behind versus the market but your investment certainly isn't trash. Furthermore, if you literally bought in the early part of 2021, and you held, then nothing bad has occurred. You are up. Again, volatility shakes out the weak hands. Long term, volatility is just noise - the price gets more and more smooth, year by year.</p>\n<p>Here's the insight. Buying and holding PLTR has worked out fine, even spectacularly, unless you bought during the big spikes in January, February, and March. Of course, if you traded against PLTR by shorting and buying puts during those times, you did fine. That's not my game, but I can see why it appeals to traders.</p>\n<p>Nevertheless, here's the key: For long-term buy-and-hold investors, PLTR is moving along just fine. Perhaps it's not winning like crazy in terms of price, but it's not exactly losing either. Our horizon is long and strong.</p>\n<p>There Is a Disturbance in the Force</p>\n<p>I'm rather surprised that there hasn't been more focus on PLTR's big picture projections. Specifically, I am talking about this:</p>\n<p><img src=\"https://static.tigerbbs.com/56383c3eaaea1d58abb1307e4fde30c6\" tg-width=\"640\" tg-height=\"362\" referrerpolicy=\"no-referrer\">Source:PLTR Q4 Business Update Presentation</p>\n<p>See the numbers there?<i>Revenue of $4 billion or more in 2025</i>.</p>\n<p>We also know that PLTR grew Q1 2021 revenue by49% year-over-year, generating $341 million across government and commercial segments. That's above the 45% revenue growth previously projected. That's a run rate of $800 million for 2021. And, for Q2 2021, revenue growth is expected to be 43%, which translates to $360 million.</p>\n<p>Those numbers for 2021 are fine and dandy and useful to hear. However, what I like more is that PLTR expects 30% growth in 2021 and the next four years. Yes, there's an implication of growth slowing in H2 of 2021, I see that too. However, we can run some pretty simple calculus with these numbers.</p>\n<p>First, we can start with the $800 million projection for 2021, check it against the 30% growth expectations. Here's how it lines up.</p>\n<ul>\n <li>2021 = $800 million</li>\n <li>2022 = $1,040 million (30% growth)</li>\n <li>2023 = $1,350 million (30% growth)</li>\n <li>2024 = $1,760 million (30% growth)</li>\n <li>2025 = $2,300 million (30% growth)</li>\n</ul>\n<p>In other words, when we start with $800 million for 2021, it's pretty obvious that the 30% growth doesn't cut it. We cannot reach $4 billion by 2025 with \"only\" 30% growth. PLTR is perhapssandbaggingto keep expectations lower. It's hard to know for sure. It could also be that they expect faster growth in 2022 through 2025. Let's run these numbers again with 40% growth.</p>\n<ul>\n <li>2021 = $800 million</li>\n <li>2022 = $1,120 million (40% growth)</li>\n <li>2023 = $1,570 million (40% growth)</li>\n <li>2024 = $2,195 million (40% growth)</li>\n <li>2025 = $3,070 million (40% growth)</li>\n</ul>\n<p>Once again, even with 40% year-over-year growth, we do not reach the $4 billion projected for 2025. Now, here's the first thing I want to point out about this oddity. My numbers might be wrong. My math might be too simple. I understand that possibility, but what this tells me is that PLTR has a different view of growth than my \"straight line\" projections. They are predators, but they are cautious too.</p>\n<p>What happens if we go a little crazy and use 49%, which is what PLTR achieved in Q1 2021. That's nearly 50% growth, of course. Here's how it looks using the same approach I've been using above.</p>\n<ul>\n <li>2021 = $800 million</li>\n <li>2022 = $1,200 million (49% growth)</li>\n <li>2023 = $1,776 million (49% growth)</li>\n <li>2024 = $2,246 million (49% growth)</li>\n <li>2025 = $3,943 million (49% growth)</li>\n</ul>\n<p>Hopefully, now it's clear why I'm so surprised that this hasn't been given more attention. While I realize I'm using \"straight line\" projections year-over-year, I'm kind of shocked that these assumptions and projections haven't been better analyzed until now. The numbers are obvious and simple, and coming straight from PLTR.</p>\n<p>Again, maybe I've got something wrong here, but to achieve $4 billion in revenue in 2025,<i>PLTR is going to have to grow by 50% every year</i>, from 2022 through 2025. That's an empirical necessity. Therefore, either PLTR is dead wrong and cannot achieve $4 billion in revenue, or perhaps they expect growth to be 50% year-over-year, or maybe that growth will be 40%, then 50%, then even higher. That is, they expect growth to accelerate.</p>\n<p>I don't believe that PLTR would knowingly publish expectations of $4 billion in 2025 without strong conviction. That is to say, it doesn't appear to be aspirational given their relatively cautious and conservative leadership. After all, theywaited 17 years to go public. Plus, with their load of government customers, it's not like they can fly by the seat of their pants. It is not in their DNA or the culture of the business from what I've seen.</p>\n<p>Peers and Price</p>\n<p>Here we take an interesting turn. Although I've written about PLTR many times, I haven't revealed something publicly before. Specifically, I have direct experience with a defense contractor. To be even more precise, I worked inside a defense contractor in a privileged position with access to an amazing crew of programmers, engineers, and technicians. That experience gave me a direct, hands-on, real-world view of how government contracting works, how the government embraces technology, and how the pieces and parts are all stitched together. I'll stop short at this point; I can't provide more details.</p>\n<p>What I can tell you is that my previous work experience has helped me take a long view on PLTR. To wit, I bought PLTR early and I haven't sold a single share. Furthermore, as you might know already, I've boughtPLTR LEAPS.</p>\n<p>Additionally, I've had several people reach out to me 1-to-1 about PLTR, including their experiences and their views. During one of these exchanges, a high ranking official and I came to agree on PLTR's peer group. I'm certainly not talking about true competitors here. I'm very specifically talking about reasonable<i>comparisons</i>for the sake of valuation. I'm talking about the general vibe of data analytics at enterprise scale, user behavior analytics, data frameworks, and so on, and so forth. Here's the list:</p>\n<ul>\n <li>Snowflake (SNOW)</li>\n <li>Alteryx (AYX)</li>\n <li>Datadog (DDOG)</li>\n <li>Salesforce (CRM)</li>\n <li>Splunk (SPLK)</li>\n</ul>\n<p>It's not necessary to agree on all of these. Instead, these are merely a reasonable cluster of companies that have similar characteristics to PLTR, although I would offer that<i>none of them would be a true direct peer</i>. I do not see even a single company that is as rich and robust as PLTR, nevertheless, we need something of a \"peer group\" to move forward.</p>\n<p>Now, with this in mind, here's how we'll proceed. Since PLTR is so newly listed and it's relatively young on the public market, I will keep things simple. I'm very interested in earnings and profits, of course, but here I want to simply compare PLTR on the basis of sales. Therefore, I feel it's somewhat rational to compare PLTR using price-to-sales. Here's how PLTR stacks up.</p>\n<p><img src=\"https://static.tigerbbs.com/c77f9e680346dc75cdad7e6073ba1c40\" tg-width=\"635\" tg-height=\"487\">Being really simple here, PLTR gets just 30-35% the P/S of SNOW. However, it gets triple that of CRM. That's quite a spread. Then again, SNOW is expecting 120% revenue growth in 2021 and86% in 2022. Right now, on the high end, SNOW has the growth edge. I am unclear about how that growth plays out into 2023, 2024, and 2025. I suspect the law of large numbers will kick in, and growth will slow. We'll see. Meanwhile, CRM is a large yet fast-growing company, clocking in with an impressive24% year-over-year revenue gain.</p>\n<p>I believe that SNOW's high growth rate will fall, as I hinted at above. Perhaps down into the 50-60% range over the next few years. We'll see. And, I believe that CRM will likely maintain a 22-25% growth rate. However, per PLTR's projections of $4 billion, I see growth above 30%. In fact, I see compound annual growth at 45-50%.</p>\n<p>In a funny way, all that doesn't even matter much. That's because the story I see is that PLTR doesn't need to massively grow beyond what we're already seeing. If we merely assume that PLTR can basically hang on to the growth it's getting right now - without any slowdown or acceleration - we can do some fun back-of-the-napkin math. The P/S ratios give us an indication that PLTR is trading at a price that is about right given its peers at this point in time. I'm not interested in SNOW vs. PLTR, or CRM vs. PLTR. I'm merely pointing out that PLTR's P/S is relatively rational given its growth. We can pivot a bit now.</p>\n<p>Here's another picture in my mind. If you take CRM and AYX, for example, both of which have a longer history than SNOW or PLTR, you can see that growing revenues translate to strongly growing stock prices. Furthermore, and more importantly, price growth roughly stays around revenue growth. Clearly, it's not perfect, but it sure looks highly correlated to me; 400% growth in AYX, and 150% growth in CRM. Timing matters here, of course, but the general trends here are telling.</p>\n<p><img src=\"https://static.tigerbbs.com/20e55c201426815f58f411103f705b88\" tg-width=\"635\" tg-height=\"453\">This makes me feel comfortable making some broad generalizations. I'm going to give year-by-year price ranges for PLTR given 30-50% growth rates. This is supported by what I've seen in PLTR's peer group, whereby P/S makes sense given growth rates, and the revenue growth vs. share price growth seems to mirror each other fairly well. I'm not trying to be exactly right here. I'm looking for potentiality, given publicly available information.</p>\n<ul>\n <li>Today = $24</li>\n <li>2022 = $31 (30% growth)</li>\n <li>2023 = $41 (30% growth)</li>\n <li>2024 = $52 (30% growth)</li>\n <li>2025 = $69 (30% growth)</li>\n</ul>\n<p>Now, let's juice the growth to 40%.</p>\n<ul>\n <li>Today = $24</li>\n <li>2022 = $34 (40% growth)</li>\n <li>2023 = $47 (40% growth)</li>\n <li>2024 = $66 (40% growth)</li>\n <li>2025 = $92 (40% growth)</li>\n</ul>\n<p>I still don't think that's accurate per my discussion up above. To achieve $4 billion in revenue, PLTR needs to hit about 50% growth every year. I'm going \"straight line\" again, with no assumptions about increasing or decreasing growth along the way. Again, I'm keeping this simple and easy. Here's how the price looks at that level of growth:</p>\n<ul>\n <li>Today = $24</li>\n <li>2022 = $36 (50% growth)</li>\n <li>2023 = $54 (50% growth)</li>\n <li>2024 = $81 (50% growth)</li>\n <li>2025 = $122 (50% growth)</li>\n</ul>\n<p><b>Perspective Is Everything</b></p>\n<p>Clearly, it's possible to be happy or sad about PLTR's price depending on when you bought. It would be understandable to be frustrated with PLTR if you bought around in the $35-45 range. On the other hand, if you bought down around $10-15, then you're probably feeling just fine. This isn't just how it works with PLTR, of course. Nevertheless, it's a healthy reminder.</p>\n<p>In the past, I've said I believe that PLTR will hit $75 by 2023. Even my relatively aggressive numbers above with 50% growth do not hit $75 in 2023, and in fact, I'm seeing $54 in 2023. However, here's the critical point. I still believe that PLTR is likely to hit $70-75 in 2023. I don't expect it to hold that price for long, but I do think because it's a growth company and because news and contacts are \"lumpy\" that we'll see spikes into the $70-75 range. Yet, since I don't trade, I'm fine sticking with my $50-55 normalized target. After all, I'm still doubling my money from this point. And it'll actually be about 5x my original investment in 2023 and 8-10x by 2025. I'm looking ahead about 3-4 years, and I'm seeing a 10-bagger for myself, given my cost basis. For most investors, PLTR appears to be an easy hold, and in fact, I think at $22-25, PLTR is a rational buy right now. I'd be far less interested in buying if the price spiked to $35 or above unless I was trading short-term options.</p>\n<p>And finally, what I'm seeing indicates that<i>PLTR is sandbagging on growth</i>, otherwise, its $4 billion in 2023 would have been revised downward. Therefore, given that large revenue target, I think it's safe to assume that PLTR actually must expect 45-50% growth, not the lower projection of 30%+ revenue growth as they have indicated in theQ4 2020andQ1 2021Earnings Call presentations. In short, I place my bets on more growth, not less. If that's true, the price will easily hold. Or, more likely, the price moves upward more aggressively over the coming years.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Is Sandbagging Growth Projections</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Is Sandbagging Growth Projections\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-07 23:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4433292-palantir-sandbagging-growth-projections><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nFirst, I look at Palantir's price action this year.\nSecond, I examine PLTR's growth projections.\nThird, I provide an overview of price-to-sales in PLTR's peer group.\nLastly, I give my ...</p>\n\n<a href=\"https://seekingalpha.com/article/4433292-palantir-sandbagging-growth-projections\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://seekingalpha.com/article/4433292-palantir-sandbagging-growth-projections","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1133174841","content_text":"Summary\n\nFirst, I look at Palantir's price action this year.\nSecond, I examine PLTR's growth projections.\nThird, I provide an overview of price-to-sales in PLTR's peer group.\nLastly, I give my thoughts on price projections out through 2025.\n\nFirst, I look at Palantir's(NYSE:PLTR)price action this year. I provide some quick thoughts on what I've seen. Second, I look into PLTR's growth projections. I believe the aggression is hidden and I reveal why I feel that way. Third, I provide an overview of price-to-sales in PLTR's peer group, and what that means going forward, especially in light of revenue growth into 2025. Lastly, I revisit the topic of price but also price projections for investors.\nRollercoaster\nHere's what's happened thus far in 2021.\nThe summary is simple. We are back where we started in January. If you bought and then closed your eyes, you would have gone absolutely nowhere. And, if your eyes were wide open, you would have experienced rather significant volatility, bouncing up against $39 but also muddling through $18. It goes without saying that PLTR has moved 50% top to bottom. But, importantly, we are back where we started.\nNow, here's where it gets interesting, because just putting money into the NASDAQ (QQQ) would give you superior returns with far less stomach-churning volatility. I'm not concerned with owning QQQ. I'm more than happy to own PLTR because, as I'll show later, it's likely to 5x my investment from this point in time. In any case, take a look at the relative calm of QQQ.\nHere I want to add another layer of paint. We started with PLTR itself, then added QQQ. What happens when we go back in time to PLTR's direct listing?\nThis is the picture that matters most to me. Here's what this means in simple terms, which is what works best in my mind. If you bought early, nothing really happened for a few weeks but then PLTR really took off. Therefore, early investors -like me- took the risk and have benefitted greatly despite all volatility after the directly public offering. With a long view, volatility is not a threat or a \"risk\", but instead, it's an opportunity to buy low.\nIn any case, if you started buying in 2021, then you're slightly behind versus the market but your investment certainly isn't trash. Furthermore, if you literally bought in the early part of 2021, and you held, then nothing bad has occurred. You are up. Again, volatility shakes out the weak hands. Long term, volatility is just noise - the price gets more and more smooth, year by year.\nHere's the insight. Buying and holding PLTR has worked out fine, even spectacularly, unless you bought during the big spikes in January, February, and March. Of course, if you traded against PLTR by shorting and buying puts during those times, you did fine. That's not my game, but I can see why it appeals to traders.\nNevertheless, here's the key: For long-term buy-and-hold investors, PLTR is moving along just fine. Perhaps it's not winning like crazy in terms of price, but it's not exactly losing either. Our horizon is long and strong.\nThere Is a Disturbance in the Force\nI'm rather surprised that there hasn't been more focus on PLTR's big picture projections. Specifically, I am talking about this:\nSource:PLTR Q4 Business Update Presentation\nSee the numbers there?Revenue of $4 billion or more in 2025.\nWe also know that PLTR grew Q1 2021 revenue by49% year-over-year, generating $341 million across government and commercial segments. That's above the 45% revenue growth previously projected. That's a run rate of $800 million for 2021. And, for Q2 2021, revenue growth is expected to be 43%, which translates to $360 million.\nThose numbers for 2021 are fine and dandy and useful to hear. However, what I like more is that PLTR expects 30% growth in 2021 and the next four years. Yes, there's an implication of growth slowing in H2 of 2021, I see that too. However, we can run some pretty simple calculus with these numbers.\nFirst, we can start with the $800 million projection for 2021, check it against the 30% growth expectations. Here's how it lines up.\n\n2021 = $800 million\n2022 = $1,040 million (30% growth)\n2023 = $1,350 million (30% growth)\n2024 = $1,760 million (30% growth)\n2025 = $2,300 million (30% growth)\n\nIn other words, when we start with $800 million for 2021, it's pretty obvious that the 30% growth doesn't cut it. We cannot reach $4 billion by 2025 with \"only\" 30% growth. PLTR is perhapssandbaggingto keep expectations lower. It's hard to know for sure. It could also be that they expect faster growth in 2022 through 2025. Let's run these numbers again with 40% growth.\n\n2021 = $800 million\n2022 = $1,120 million (40% growth)\n2023 = $1,570 million (40% growth)\n2024 = $2,195 million (40% growth)\n2025 = $3,070 million (40% growth)\n\nOnce again, even with 40% year-over-year growth, we do not reach the $4 billion projected for 2025. Now, here's the first thing I want to point out about this oddity. My numbers might be wrong. My math might be too simple. I understand that possibility, but what this tells me is that PLTR has a different view of growth than my \"straight line\" projections. They are predators, but they are cautious too.\nWhat happens if we go a little crazy and use 49%, which is what PLTR achieved in Q1 2021. That's nearly 50% growth, of course. Here's how it looks using the same approach I've been using above.\n\n2021 = $800 million\n2022 = $1,200 million (49% growth)\n2023 = $1,776 million (49% growth)\n2024 = $2,246 million (49% growth)\n2025 = $3,943 million (49% growth)\n\nHopefully, now it's clear why I'm so surprised that this hasn't been given more attention. While I realize I'm using \"straight line\" projections year-over-year, I'm kind of shocked that these assumptions and projections haven't been better analyzed until now. The numbers are obvious and simple, and coming straight from PLTR.\nAgain, maybe I've got something wrong here, but to achieve $4 billion in revenue in 2025,PLTR is going to have to grow by 50% every year, from 2022 through 2025. That's an empirical necessity. Therefore, either PLTR is dead wrong and cannot achieve $4 billion in revenue, or perhaps they expect growth to be 50% year-over-year, or maybe that growth will be 40%, then 50%, then even higher. That is, they expect growth to accelerate.\nI don't believe that PLTR would knowingly publish expectations of $4 billion in 2025 without strong conviction. That is to say, it doesn't appear to be aspirational given their relatively cautious and conservative leadership. After all, theywaited 17 years to go public. Plus, with their load of government customers, it's not like they can fly by the seat of their pants. It is not in their DNA or the culture of the business from what I've seen.\nPeers and Price\nHere we take an interesting turn. Although I've written about PLTR many times, I haven't revealed something publicly before. Specifically, I have direct experience with a defense contractor. To be even more precise, I worked inside a defense contractor in a privileged position with access to an amazing crew of programmers, engineers, and technicians. That experience gave me a direct, hands-on, real-world view of how government contracting works, how the government embraces technology, and how the pieces and parts are all stitched together. I'll stop short at this point; I can't provide more details.\nWhat I can tell you is that my previous work experience has helped me take a long view on PLTR. To wit, I bought PLTR early and I haven't sold a single share. Furthermore, as you might know already, I've boughtPLTR LEAPS.\nAdditionally, I've had several people reach out to me 1-to-1 about PLTR, including their experiences and their views. During one of these exchanges, a high ranking official and I came to agree on PLTR's peer group. I'm certainly not talking about true competitors here. I'm very specifically talking about reasonablecomparisonsfor the sake of valuation. I'm talking about the general vibe of data analytics at enterprise scale, user behavior analytics, data frameworks, and so on, and so forth. Here's the list:\n\nSnowflake (SNOW)\nAlteryx (AYX)\nDatadog (DDOG)\nSalesforce (CRM)\nSplunk (SPLK)\n\nIt's not necessary to agree on all of these. Instead, these are merely a reasonable cluster of companies that have similar characteristics to PLTR, although I would offer thatnone of them would be a true direct peer. I do not see even a single company that is as rich and robust as PLTR, nevertheless, we need something of a \"peer group\" to move forward.\nNow, with this in mind, here's how we'll proceed. Since PLTR is so newly listed and it's relatively young on the public market, I will keep things simple. I'm very interested in earnings and profits, of course, but here I want to simply compare PLTR on the basis of sales. Therefore, I feel it's somewhat rational to compare PLTR using price-to-sales. Here's how PLTR stacks up.\nBeing really simple here, PLTR gets just 30-35% the P/S of SNOW. However, it gets triple that of CRM. That's quite a spread. Then again, SNOW is expecting 120% revenue growth in 2021 and86% in 2022. Right now, on the high end, SNOW has the growth edge. I am unclear about how that growth plays out into 2023, 2024, and 2025. I suspect the law of large numbers will kick in, and growth will slow. We'll see. Meanwhile, CRM is a large yet fast-growing company, clocking in with an impressive24% year-over-year revenue gain.\nI believe that SNOW's high growth rate will fall, as I hinted at above. Perhaps down into the 50-60% range over the next few years. We'll see. And, I believe that CRM will likely maintain a 22-25% growth rate. However, per PLTR's projections of $4 billion, I see growth above 30%. In fact, I see compound annual growth at 45-50%.\nIn a funny way, all that doesn't even matter much. That's because the story I see is that PLTR doesn't need to massively grow beyond what we're already seeing. If we merely assume that PLTR can basically hang on to the growth it's getting right now - without any slowdown or acceleration - we can do some fun back-of-the-napkin math. The P/S ratios give us an indication that PLTR is trading at a price that is about right given its peers at this point in time. I'm not interested in SNOW vs. PLTR, or CRM vs. PLTR. I'm merely pointing out that PLTR's P/S is relatively rational given its growth. We can pivot a bit now.\nHere's another picture in my mind. If you take CRM and AYX, for example, both of which have a longer history than SNOW or PLTR, you can see that growing revenues translate to strongly growing stock prices. Furthermore, and more importantly, price growth roughly stays around revenue growth. Clearly, it's not perfect, but it sure looks highly correlated to me; 400% growth in AYX, and 150% growth in CRM. Timing matters here, of course, but the general trends here are telling.\nThis makes me feel comfortable making some broad generalizations. I'm going to give year-by-year price ranges for PLTR given 30-50% growth rates. This is supported by what I've seen in PLTR's peer group, whereby P/S makes sense given growth rates, and the revenue growth vs. share price growth seems to mirror each other fairly well. I'm not trying to be exactly right here. I'm looking for potentiality, given publicly available information.\n\nToday = $24\n2022 = $31 (30% growth)\n2023 = $41 (30% growth)\n2024 = $52 (30% growth)\n2025 = $69 (30% growth)\n\nNow, let's juice the growth to 40%.\n\nToday = $24\n2022 = $34 (40% growth)\n2023 = $47 (40% growth)\n2024 = $66 (40% growth)\n2025 = $92 (40% growth)\n\nI still don't think that's accurate per my discussion up above. To achieve $4 billion in revenue, PLTR needs to hit about 50% growth every year. I'm going \"straight line\" again, with no assumptions about increasing or decreasing growth along the way. Again, I'm keeping this simple and easy. Here's how the price looks at that level of growth:\n\nToday = $24\n2022 = $36 (50% growth)\n2023 = $54 (50% growth)\n2024 = $81 (50% growth)\n2025 = $122 (50% growth)\n\nPerspective Is Everything\nClearly, it's possible to be happy or sad about PLTR's price depending on when you bought. It would be understandable to be frustrated with PLTR if you bought around in the $35-45 range. On the other hand, if you bought down around $10-15, then you're probably feeling just fine. This isn't just how it works with PLTR, of course. Nevertheless, it's a healthy reminder.\nIn the past, I've said I believe that PLTR will hit $75 by 2023. Even my relatively aggressive numbers above with 50% growth do not hit $75 in 2023, and in fact, I'm seeing $54 in 2023. However, here's the critical point. I still believe that PLTR is likely to hit $70-75 in 2023. I don't expect it to hold that price for long, but I do think because it's a growth company and because news and contacts are \"lumpy\" that we'll see spikes into the $70-75 range. Yet, since I don't trade, I'm fine sticking with my $50-55 normalized target. After all, I'm still doubling my money from this point. And it'll actually be about 5x my original investment in 2023 and 8-10x by 2025. I'm looking ahead about 3-4 years, and I'm seeing a 10-bagger for myself, given my cost basis. For most investors, PLTR appears to be an easy hold, and in fact, I think at $22-25, PLTR is a rational buy right now. I'd be far less interested in buying if the price spiked to $35 or above unless I was trading short-term options.\nAnd finally, what I'm seeing indicates thatPLTR is sandbagging on growth, otherwise, its $4 billion in 2023 would have been revised downward. Therefore, given that large revenue target, I think it's safe to assume that PLTR actually must expect 45-50% growth, not the lower projection of 30%+ revenue growth as they have indicated in theQ4 2020andQ1 2021Earnings Call presentations. In short, I place my bets on more growth, not less. If that's true, the price will easily hold. Or, more likely, the price moves upward more aggressively over the coming years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":27,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":134188427,"gmtCreate":1622211390569,"gmtModify":1704181616242,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>?","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>?","text":"$Tiger Brokers(TIGR)$?","images":[{"img":"https://static.tigerbbs.com/43632d82ad61cb7886cbadd8f531bd28","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/134188427","isVote":1,"tweetType":1,"viewCount":120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":189813876,"gmtCreate":1623250697595,"gmtModify":1704199439409,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>gogogo","text":"$ContextLogic Inc.(WISH)$gogogo","images":[{"img":"https://static.tigerbbs.com/6091aeffbbd8fcfb948505af02f717db","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/189813876","isVote":1,"tweetType":1,"viewCount":487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":114540807,"gmtCreate":1623081887809,"gmtModify":1704195772926,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogo","listText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogo","text":"$Skillz Inc(SKLZ)$gogo","images":[{"img":"https://static.tigerbbs.com/71edab0c6e1807e11f235c676f0c3332","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114540807","isVote":1,"tweetType":1,"viewCount":178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":112062897,"gmtCreate":1622826044519,"gmtModify":1704192065606,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>&nbsp;finally green","listText":"<a href=\"https://laohu8.com/S/MVIS\">$Microvision(MVIS)$</a>&nbsp;finally green","text":"$Microvision(MVIS)$ finally green","images":[{"img":"https://static.tigerbbs.com/c1afa9547683014fdbdb770aa2b1170b","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/112062897","isVote":1,"tweetType":1,"viewCount":187,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":370063890,"gmtCreate":1618536849910,"gmtModify":1704712364610,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Latest","listText":"Latest","text":"Latest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/370063890","repostId":"2127888790","repostType":4,"repost":{"id":"2127888790","pubTimestamp":1618535981,"share":"https://ttm.financial/m/news/2127888790?lang=&edition=fundamental","pubTime":"2021-04-16 09:19","market":"us","language":"en","title":"Pinterest Earnings: What to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2127888790","media":"Motley Fool","summary":"With shares of the social media company up 347% over the last year, investors are pinning their hopes on a strong first-quarter earnings report.","content":"<p><b>Pinterest </b>(NYSE:PINS) is slated to report its first-quarter 2021 results after the market close on Tuesday, April 27. A conference call with analysts is scheduled for the same day at 6 p.m. EDT.</p>\n<p>It seems likely that many investors will be approaching the visual image-discovery platform operator's release with much optimism. The company performed well last year, thanks in part to a tailwind from the COVID-19 pandemic, which boosted overall social media use.</p>\n<p>Enthused by the company's robust recent performance and bright outlook, investors have been pouring into the growth stock. Shares of Pinterest have gained a whopping 347% over the <a href=\"https://laohu8.com/S/AONE\">one</a>-year period through April 14, and are only about 6% off their all-time high set in mid-February. The <b>S&amp;P 500</b> index has returned about 47% over the last year.</p>\n<p>Here's what to watch in Pinterest's upcoming Q1 report.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5e64552d578a2bba047cd8c4085fccdd\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>Pinterest's key numbers</h2>\n<p>Below are the company's results from Q1 2020, its Q1 2021 guidance, and Wall Street's consensus estimates to use as benchmarks.</p>\n<table>\n <thead>\n  <tr>\n   <th>Metric</th>\n   <th>Q1 2020 Result</th>\n   <th>Pinterest's Q1 2021 Guidance</th>\n   <th>Wall Street's Q1 2021 Consensus Estimate</th>\n   <th>Wall Street's Projected Change (YOY)</th>\n  </tr>\n  <tr>\n   <td><p>Revenue</p></td>\n   <td><p>$271.9 million</p></td>\n   <td><p>YOY growth in low-70% range</p></td>\n   <td><p>$472.7 million</p></td>\n   <td><p>74%</p></td>\n  </tr>\n  <tr>\n   <td><p>Adjusted earnings per share (EPS)</p></td>\n   <td>($0.10)</td>\n   <td>N/A</td>\n   <td>$0.08</td>\n   <td><p>N/A. Result expected to flip to positive from negative.</p></td>\n  </tr>\n </thead>\n</table>\n<p>Data sources: Pinterest and Yahoo! Finance. YOY = year over year. Note: Pinterest doesn't issue earnings guidance.</p>\n<p>Given how new the company is to the public markets (it held its initial public offering in April 2019), revenue growth is probably the most important metric to use to gauge its overall performance.</p>\n<p>For context, in the fourth quarter of 2020, Pinterest's revenue soared 76% year over year to $705.6 million. Adjusted EPS skyrocketed 258% to $0.43. Results for both the top and bottom lines sped by Wall Street's expectations.</p>\n<h2>Key user stats</h2>\n<p>Like other social media companies, Pinterest has an advertising-based business model. The two key metrics that determine its revenue are the number of monthly active users (MAUs) and global average revenue per user (ARPU).</p>\n<p>Last quarter, the company's MAUs surged 37% year over year to 459 million, and its ARPU jumped 29% to $1.57.</p>\n<p>For some context, for the same quarter, Q4 2020, social media giant <b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b> had 2.8 billion MAUs -- about six times as many as Pinterest. This fact suggests that Pinterest still has a long runway for growth.</p>\n<h2>Second-quarter 2021 guidance</h2>\n<p>The company's second-quarter outlook, relative to Wall Street's expectations, will probably be the biggest factor in any post-earnings stock price move. That's because the stock market is a forward-looking machine.</p>\n<p>For Q2, analysts are modeling for Pinterest's revenue to soar 94% year over year to $528 million. On the bottom line, the consensus estimate is for adjusted EPS of $0.10, compared to an adjusted loss of $0.07 per share in the year-ago period.</p>\n<p>Pin the date: Pinterest's release of its Q1 results is scheduled for after the market close on Tuesday, April 27.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pinterest Earnings: What to Watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPinterest Earnings: What to Watch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-16 09:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/15/pinterest-earnings-what-to-watch/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pinterest (NYSE:PINS) is slated to report its first-quarter 2021 results after the market close on Tuesday, April 27. A conference call with analysts is scheduled for the same day at 6 p.m. EDT.\nIt ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/15/pinterest-earnings-what-to-watch/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PINS":"Pinterest, Inc."},"source_url":"https://www.fool.com/investing/2021/04/15/pinterest-earnings-what-to-watch/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2127888790","content_text":"Pinterest (NYSE:PINS) is slated to report its first-quarter 2021 results after the market close on Tuesday, April 27. A conference call with analysts is scheduled for the same day at 6 p.m. EDT.\nIt seems likely that many investors will be approaching the visual image-discovery platform operator's release with much optimism. The company performed well last year, thanks in part to a tailwind from the COVID-19 pandemic, which boosted overall social media use.\nEnthused by the company's robust recent performance and bright outlook, investors have been pouring into the growth stock. Shares of Pinterest have gained a whopping 347% over the one-year period through April 14, and are only about 6% off their all-time high set in mid-February. The S&P 500 index has returned about 47% over the last year.\nHere's what to watch in Pinterest's upcoming Q1 report.\nImage source: Getty Images.\nPinterest's key numbers\nBelow are the company's results from Q1 2020, its Q1 2021 guidance, and Wall Street's consensus estimates to use as benchmarks.\n\n\n\nMetric\nQ1 2020 Result\nPinterest's Q1 2021 Guidance\nWall Street's Q1 2021 Consensus Estimate\nWall Street's Projected Change (YOY)\n\n\nRevenue\n$271.9 million\nYOY growth in low-70% range\n$472.7 million\n74%\n\n\nAdjusted earnings per share (EPS)\n($0.10)\nN/A\n$0.08\nN/A. Result expected to flip to positive from negative.\n\n\n\nData sources: Pinterest and Yahoo! Finance. YOY = year over year. Note: Pinterest doesn't issue earnings guidance.\nGiven how new the company is to the public markets (it held its initial public offering in April 2019), revenue growth is probably the most important metric to use to gauge its overall performance.\nFor context, in the fourth quarter of 2020, Pinterest's revenue soared 76% year over year to $705.6 million. Adjusted EPS skyrocketed 258% to $0.43. Results for both the top and bottom lines sped by Wall Street's expectations.\nKey user stats\nLike other social media companies, Pinterest has an advertising-based business model. The two key metrics that determine its revenue are the number of monthly active users (MAUs) and global average revenue per user (ARPU).\nLast quarter, the company's MAUs surged 37% year over year to 459 million, and its ARPU jumped 29% to $1.57.\nFor some context, for the same quarter, Q4 2020, social media giant Facebook had 2.8 billion MAUs -- about six times as many as Pinterest. This fact suggests that Pinterest still has a long runway for growth.\nSecond-quarter 2021 guidance\nThe company's second-quarter outlook, relative to Wall Street's expectations, will probably be the biggest factor in any post-earnings stock price move. That's because the stock market is a forward-looking machine.\nFor Q2, analysts are modeling for Pinterest's revenue to soar 94% year over year to $528 million. On the bottom line, the consensus estimate is for adjusted EPS of $0.10, compared to an adjusted loss of $0.07 per share in the year-ago period.\nPin the date: Pinterest's release of its Q1 results is scheduled for after the market close on Tuesday, April 27.","news_type":1},"isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183346512,"gmtCreate":1623311201636,"gmtModify":1704200609595,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183346512","repostId":"2142244006","repostType":4,"repost":{"id":"2142244006","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623310084,"share":"https://ttm.financial/m/news/2142244006?lang=&edition=fundamental","pubTime":"2021-06-10 15:28","market":"uk","language":"en","title":"ECB to keep money taps wide open even as recovery takes hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2142244006","media":"Reuters","summary":"FRANKFURT, June 10 (Reuters) - The European Central Bank is all but certain to maintain a generous f","content":"<p>FRANKFURT, June 10 (Reuters) - The European Central Bank is all but certain to maintain a generous flow of stimulus when policymakers meet on Thursday, fearing that higher borrowing costs could smother a still nascent recovery.</p>\n<p>Just emerging from a pandemic-induced double-dip recession, the 19-country euro zone economy has relied on unprecedented ECB stimulus to stay afloat. And even as growth surges with the easing of COVID-19 restrictions, policymakers appear keen to err on the side of caution.</p>\n<p>Recent comments from ECB President Christine Lagarde and board member Fabio Panetta suggest the June discussion effectively ended even before Thursday's meeting, with a cut in bond purchases unlikely, even if policymakers acknowledge an improvement in growth prospects and the rapid pace of vaccinations.</p>\n<p>Panetta flatly rejected any reduction in emergency bond buys while Lagarde said it was \"far too early\" to discuss tapering the bank's 1.85 trillion euro Pandemic Emergency Purchases Programme (PEPP).</p>\n<p>While policymakers could still opt for a different course, they usually line up behind their president and rarely make changes to proposals brought to the table by the six-member Executive Board.</p>\n<p>Weak medium-term inflation prospects are the key rationale for maintaining copious support but policymakers are also concerned that borrowing costs are inching up, so that any retreat by the ECB might risk setting off potentially dangerous market volatility.</p>\n<p>\"The longer the ECB waits before it admits that the rationale to run its Pandemic Emergency Purchase Programme at full speed is no longer as strong as it was in March, the less gentle could the transition to fewer asset purchases be in the future,\" Berenberg economist Holger Schmieding said.</p>\n<p>\"If so, bond yields could ratchet up more strongly after a while.\"</p>\n<p>Euro zone government bond yields were trading near their lowest levels since April on Thursday.</p>\n<p><b>SEPTEMBER</b></p>\n<p>Further complicating the picture, the ECB is likely to nudge up most if not all of its growth and inflation forecasts and could even upgrade its guidance on growth, declaring risks \"balanced\" to replace a long-standing line about downside risks.</p>\n<p>Inflation is also surging and last month exceeded the ECB's target of just under 2%, a mark it has undershot for most of the last decade.</p>\n<p>But the economy will need another year just to grow back to its pre-pandemic level and the inflation jump is mostly a reversal of last year's energy price plunge, not the start of a new era of price pressures, policymakers have said.</p>\n<p>Underlying price pressures, a key focus for the ECB, remain anaemic and wage growth is weak, pointing to excessively low inflation for years to come.</p>\n<p>Europe is also far behind the United States in its recovery so any withdrawal of support ahead of the Federal Reserve would be seen as a dangerous signal.</p>\n<p>U.S. inflation data, due to be published at 1230 GMT, is expected to show a 4.7% increase in prices last month, up from 4.2% in April, with a stronger reading likely to reignite speculation about fewer bond purchases from the Fed.</p>\n<p>Wholesale prices in both Japan and China rose at their fastest pace in over a decade due to surging commodity prices.</p>\n<p>\"Given the markets' nervousness about taper talk and the ECB's firm wish to distance itself from the taper preparations in the U.S. over the summer, the ECB is likely to signal unchanged purchases until September,\" Anatoli Annenkov, an economist at <a href=\"https://laohu8.com/S/SCGLF\">Societe Generale</a> said.</p>\n<p>But the end of the emergency buys is coming and policymakers are unlikely to enlarge the scheme or extend it beyond its scheduled end in March 2022, given the economy's solid rebound, economists polled by Reuters said.</p>\n<p>That will put pressure on policymakers to start plotting a course beyond the emergency bond buys. Some signals of that could come as soon as September, economists say.</p>\n<p>As medium-term inflation prospects remain muted, decreasing buying under PEPP is likely to be accompanied by an expansion of the ECB's less flexible but open-ended Asset Purchase Programme and signals that some ECB support, even if less generous, will continue well into the future.</p>\n<p>The ECB will announce its policy decision at 1145 GMT, followed by Lagarde's news conference at 1230 GMT. With Thursday's decision, the bank's deposit rate, its benchmark, will remain at minus 0.5%.</p>\n<p>(Reporting by Balazs Koranyi; Editing by Catherine Evans and Toby Chopra)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ECB to keep money taps wide open even as recovery takes hold</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nECB to keep money taps wide open even as recovery takes hold\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-10 15:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>FRANKFURT, June 10 (Reuters) - The European Central Bank is all but certain to maintain a generous flow of stimulus when policymakers meet on Thursday, fearing that higher borrowing costs could smother a still nascent recovery.</p>\n<p>Just emerging from a pandemic-induced double-dip recession, the 19-country euro zone economy has relied on unprecedented ECB stimulus to stay afloat. And even as growth surges with the easing of COVID-19 restrictions, policymakers appear keen to err on the side of caution.</p>\n<p>Recent comments from ECB President Christine Lagarde and board member Fabio Panetta suggest the June discussion effectively ended even before Thursday's meeting, with a cut in bond purchases unlikely, even if policymakers acknowledge an improvement in growth prospects and the rapid pace of vaccinations.</p>\n<p>Panetta flatly rejected any reduction in emergency bond buys while Lagarde said it was \"far too early\" to discuss tapering the bank's 1.85 trillion euro Pandemic Emergency Purchases Programme (PEPP).</p>\n<p>While policymakers could still opt for a different course, they usually line up behind their president and rarely make changes to proposals brought to the table by the six-member Executive Board.</p>\n<p>Weak medium-term inflation prospects are the key rationale for maintaining copious support but policymakers are also concerned that borrowing costs are inching up, so that any retreat by the ECB might risk setting off potentially dangerous market volatility.</p>\n<p>\"The longer the ECB waits before it admits that the rationale to run its Pandemic Emergency Purchase Programme at full speed is no longer as strong as it was in March, the less gentle could the transition to fewer asset purchases be in the future,\" Berenberg economist Holger Schmieding said.</p>\n<p>\"If so, bond yields could ratchet up more strongly after a while.\"</p>\n<p>Euro zone government bond yields were trading near their lowest levels since April on Thursday.</p>\n<p><b>SEPTEMBER</b></p>\n<p>Further complicating the picture, the ECB is likely to nudge up most if not all of its growth and inflation forecasts and could even upgrade its guidance on growth, declaring risks \"balanced\" to replace a long-standing line about downside risks.</p>\n<p>Inflation is also surging and last month exceeded the ECB's target of just under 2%, a mark it has undershot for most of the last decade.</p>\n<p>But the economy will need another year just to grow back to its pre-pandemic level and the inflation jump is mostly a reversal of last year's energy price plunge, not the start of a new era of price pressures, policymakers have said.</p>\n<p>Underlying price pressures, a key focus for the ECB, remain anaemic and wage growth is weak, pointing to excessively low inflation for years to come.</p>\n<p>Europe is also far behind the United States in its recovery so any withdrawal of support ahead of the Federal Reserve would be seen as a dangerous signal.</p>\n<p>U.S. inflation data, due to be published at 1230 GMT, is expected to show a 4.7% increase in prices last month, up from 4.2% in April, with a stronger reading likely to reignite speculation about fewer bond purchases from the Fed.</p>\n<p>Wholesale prices in both Japan and China rose at their fastest pace in over a decade due to surging commodity prices.</p>\n<p>\"Given the markets' nervousness about taper talk and the ECB's firm wish to distance itself from the taper preparations in the U.S. over the summer, the ECB is likely to signal unchanged purchases until September,\" Anatoli Annenkov, an economist at <a href=\"https://laohu8.com/S/SCGLF\">Societe Generale</a> said.</p>\n<p>But the end of the emergency buys is coming and policymakers are unlikely to enlarge the scheme or extend it beyond its scheduled end in March 2022, given the economy's solid rebound, economists polled by Reuters said.</p>\n<p>That will put pressure on policymakers to start plotting a course beyond the emergency bond buys. Some signals of that could come as soon as September, economists say.</p>\n<p>As medium-term inflation prospects remain muted, decreasing buying under PEPP is likely to be accompanied by an expansion of the ECB's less flexible but open-ended Asset Purchase Programme and signals that some ECB support, even if less generous, will continue well into the future.</p>\n<p>The ECB will announce its policy decision at 1145 GMT, followed by Lagarde's news conference at 1230 GMT. With Thursday's decision, the bank's deposit rate, its benchmark, will remain at minus 0.5%.</p>\n<p>(Reporting by Balazs Koranyi; Editing by Catherine Evans and Toby Chopra)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142244006","content_text":"FRANKFURT, June 10 (Reuters) - The European Central Bank is all but certain to maintain a generous flow of stimulus when policymakers meet on Thursday, fearing that higher borrowing costs could smother a still nascent recovery.\nJust emerging from a pandemic-induced double-dip recession, the 19-country euro zone economy has relied on unprecedented ECB stimulus to stay afloat. And even as growth surges with the easing of COVID-19 restrictions, policymakers appear keen to err on the side of caution.\nRecent comments from ECB President Christine Lagarde and board member Fabio Panetta suggest the June discussion effectively ended even before Thursday's meeting, with a cut in bond purchases unlikely, even if policymakers acknowledge an improvement in growth prospects and the rapid pace of vaccinations.\nPanetta flatly rejected any reduction in emergency bond buys while Lagarde said it was \"far too early\" to discuss tapering the bank's 1.85 trillion euro Pandemic Emergency Purchases Programme (PEPP).\nWhile policymakers could still opt for a different course, they usually line up behind their president and rarely make changes to proposals brought to the table by the six-member Executive Board.\nWeak medium-term inflation prospects are the key rationale for maintaining copious support but policymakers are also concerned that borrowing costs are inching up, so that any retreat by the ECB might risk setting off potentially dangerous market volatility.\n\"The longer the ECB waits before it admits that the rationale to run its Pandemic Emergency Purchase Programme at full speed is no longer as strong as it was in March, the less gentle could the transition to fewer asset purchases be in the future,\" Berenberg economist Holger Schmieding said.\n\"If so, bond yields could ratchet up more strongly after a while.\"\nEuro zone government bond yields were trading near their lowest levels since April on Thursday.\nSEPTEMBER\nFurther complicating the picture, the ECB is likely to nudge up most if not all of its growth and inflation forecasts and could even upgrade its guidance on growth, declaring risks \"balanced\" to replace a long-standing line about downside risks.\nInflation is also surging and last month exceeded the ECB's target of just under 2%, a mark it has undershot for most of the last decade.\nBut the economy will need another year just to grow back to its pre-pandemic level and the inflation jump is mostly a reversal of last year's energy price plunge, not the start of a new era of price pressures, policymakers have said.\nUnderlying price pressures, a key focus for the ECB, remain anaemic and wage growth is weak, pointing to excessively low inflation for years to come.\nEurope is also far behind the United States in its recovery so any withdrawal of support ahead of the Federal Reserve would be seen as a dangerous signal.\nU.S. inflation data, due to be published at 1230 GMT, is expected to show a 4.7% increase in prices last month, up from 4.2% in April, with a stronger reading likely to reignite speculation about fewer bond purchases from the Fed.\nWholesale prices in both Japan and China rose at their fastest pace in over a decade due to surging commodity prices.\n\"Given the markets' nervousness about taper talk and the ECB's firm wish to distance itself from the taper preparations in the U.S. over the summer, the ECB is likely to signal unchanged purchases until September,\" Anatoli Annenkov, an economist at Societe Generale said.\nBut the end of the emergency buys is coming and policymakers are unlikely to enlarge the scheme or extend it beyond its scheduled end in March 2022, given the economy's solid rebound, economists polled by Reuters said.\nThat will put pressure on policymakers to start plotting a course beyond the emergency bond buys. Some signals of that could come as soon as September, economists say.\nAs medium-term inflation prospects remain muted, decreasing buying under PEPP is likely to be accompanied by an expansion of the ECB's less flexible but open-ended Asset Purchase Programme and signals that some ECB support, even if less generous, will continue well into the future.\nThe ECB will announce its policy decision at 1145 GMT, followed by Lagarde's news conference at 1230 GMT. With Thursday's decision, the bank's deposit rate, its benchmark, will remain at minus 0.5%.\n(Reporting by Balazs Koranyi; Editing by Catherine Evans and Toby Chopra)","news_type":1},"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322653334,"gmtCreate":1615805123728,"gmtModify":1704786744043,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OEG\">$Orbital Energy Group(OEG)$</a>?","listText":"<a href=\"https://laohu8.com/S/OEG\">$Orbital Energy Group(OEG)$</a>?","text":"$Orbital Energy Group(OEG)$?","images":[{"img":"https://static.tigerbbs.com/18be4e49dece841d0d4b89cfea929fd4","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322653334","isVote":1,"tweetType":1,"viewCount":111,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":328305242,"gmtCreate":1615485288486,"gmtModify":1704783561590,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>?","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>?","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$?","images":[{"img":"https://static.tigerbbs.com/a2607c6204ca3a0807d08aeffe8b1b19","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/328305242","isVote":1,"tweetType":1,"viewCount":18,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":117776308,"gmtCreate":1623162662904,"gmtModify":1704197453700,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogogo","text":"$Skillz Inc(SKLZ)$gogogo","images":[{"img":"https://static.tigerbbs.com/4b3d17b1e1e777f505d100c96a927008","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117776308","isVote":1,"tweetType":1,"viewCount":156,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":114557491,"gmtCreate":1623081845713,"gmtModify":1704195771473,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114557491","repostId":"2141127236","repostType":4,"repost":{"id":"2141127236","pubTimestamp":1623079500,"share":"https://ttm.financial/m/news/2141127236?lang=&edition=fundamental","pubTime":"2021-06-07 23:25","market":"us","language":"en","title":"5 Supercharged Stocks That Are Going to the Moon","url":"https://stock-news.laohu8.com/highlight/detail?id=2141127236","media":"Motley Fool","summary":"These innovative, high-quality businesses should reward long-term investors with monster gains.","content":"<p>Although the year isn't even halfway over, it'll almost certainly be remembered as the year retail investors firmly asserted themselves on Wall Street.</p><p>Since January, retail investors have effectively banded together to buy shares and out-of-the-money call options in stocks with very high levels of short interest. The intent of these retail groups is to effect a short squeeze -- a short-term event that sees pessimists (short-sellers) run for the exit at once, causing a company's share price to skyrocket -- and send these stocks \"to the moon.\"</p><p>Unfortunately, nearly all of the companies retail traders have targeted have poor fundamental track records and/or frightening balance sheets. In short, these gains aren't going to be sustainable.</p><p>If you want to own stakes in companies with a real chance of \"going to the moon,\" you have to buy into innovative businesses with tangible growth prospects. The following five supercharged stocks fit the bill perfectly.</p><h3>Sea Limited</h3><p>Growth stock investors who are patient will likely watch Singapore-based <b>Sea Limited</b> (NYSE:SE) go to the moon over the next decade. That's because Sea brings not <a href=\"https://laohu8.com/S/AONE\">one</a> or even two, but three rapidly growing and differentiated operating segments to the table.</p><p>For the time being, Sea's digital entertainment division is generating all of its earnings before interest, taxes, depreciation, and amortization (EBITDA). The company ended March with almost 649 million quarterly active gamers, 12.3% of which were paying customers. What's notable is that the number paying customers jumped from 8.9% in the year-ago quarter to 12.3%.</p><p>However, the segment that'll create far more long-term value is its e-commerce shopping platform Shopee. The most downloaded e-commerce app in Southeastern Asia saw gross merchandise value more than double to $12.6 billion in Q1 2021, with gross orders up 153% to 1.1 billion. Even though the ongoing pandemic is helping funnel consumers into online channels, it's the rise of the middle class in emerging markets that'll be responsible for Sea's ascent.</p><p>To round things out, Sea also has over 26 million paying mobile wallet customers. Since it operates in a number of underbanked countries, offering access to digital financial services could be another game-changer for the company and its consumers.</p><h3>Jushi Holdings</h3><p>Small-cap U.S. marijuana stock <b>Jushi Holdings</b> (OTC:JUSHF) also has a pretty good chance of shooting to the moon for long-term investors.</p><p>By 2025, <a href=\"https://laohu8.com/S/NFC.U\">New Frontier</a> Data has forecast more than $41 billion in annual U.S. weed sales. Like other multistate operators, Jushi is angling for its piece of this fast-growing pie. But it's doing so a bit differently. Most of its revenue is expected to come from Pennsylvania, Illinois, and Virginia. Why these three states? The answer is they all limit the number of retail licenses they issue. This is to say that Jushi is going to face limited or nonexistent competition in these states, which'll allow it to successfully build up its brand awareness and create a loyal following.</p><p>Jushi is also well capitalized and not afraid to make acquisitions to bolster its retail or cultivation presence. It boosted its presence in Pennsylvania and Virginia earlier this year and recently closed on the purchase of two dispensaries in California. The Golden State is the largest pot market in the world, by annual sales.</p><p>Most marijuana stocks are valued at anywhere between 3 and 7 times forward-year sales. As for Jushi, it can be scooped up for less than 2 times forward-year sales, which is a big-time bargain.</p><h3>Airbnb</h3><p>Another innovative business that can moonshot higher over the long-run is stay-and-hosting platform <b>Airbnb</b> (NASDAQ:ABNB).</p><p>Airbnb has the potential to completely transform the traditional hotel and travel industry. By the company's own admission, it has about 4 million hosts worldwide. But this is just the tip of the iceberg. There are around 130 million households just in the U.S., and likely well over 1 billion worldwide. Once people become aware of the cash flow potential of listing their property on Airbnb, we'll likely see this 4 million figure double many times over.</p><p>Don't overlook Airbnb's role outside of its foundational hosting marketplace, either. The company's Experiences -- activities led by local experts -- represents just <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the many ways Airbnb can partner with hosts or popular travel destination businesses to sell inclusive packages and build customer loyalty.</p><p>Maybe most impressive of all is how many people are familiar with Airbnb and its marketplace. Word-of-mouth advertising is a cheap yet powerful tool, and Airbnb has harnessed it perfectly to build a strong brand identity.</p><h3>The Original BARK Company</h3><p><b>The Original BARK Company </b>(NYSE:BARK), which officially completed its merger with a special purpose acquisition company (SPAC) last week, is another supercharged growth stock that has moonshot potential written all over it.</p><p>The BARK Company, which is probably best known as BarkBox, provides dog-focused products and services to pet owners. Though you'll find its products in 23,000 retail doors, it's predominantly an e-commerce company that relies on high-margin subscriptions. As of the end of March, it had 1.2 million subscribers, which was up 91% from the prior-year period. What's more, the company's S-1 filing notes that monthly product retention is higher than it's ever been, which signifies that a high percentage of subscribers aren't cancelling.</p><p>Innovation is also important for BARK. Last year, it introduced Bark Home, which allows dog owners to purchase basic-need accessories like collars and beds, and Bark Eats, a program that personalizes and delivers a high-quality dry food diet to dog owners.</p><p>If this isn't convincing enough, consider that it's been more than a quarter of a century since year-over-year pet expenditures declined in the United States. This year alone, the American Pet Products Association expects nearly $110 billion will be spent on companion animals, $44.1 billion of which is on food and treats, which is BarkBox's specialty.</p><h3>Amazon</h3><p>Last but not least, e-commerce giant <b>Amazon</b> (NASDAQ:AMZN) can still go to the moon. You might be skeptical of one of the world's largest companies delivering outsized returns, but a closer inspection at its e-commerce dominance and cash flow will turn that skepticism into optimism.</p><p>As you're likely aware, Amazon is the 800-pound gorilla in the U.S. online retail space. A recently released report from eMarketer estimates Amazon will control 40.4% of all e-commerce sales in the U.S. this year. Despite retail margins generally being razor thin, the company has been able to boost its revenue and grow its online dominance by selling over 200 million Prime subscriptions. The revenue collected from these memberships helps Amazon undercut brick-and-mortar retailers on price. And it certainly doesn't hurt that Prime members are incented to stay within the company's ecosystem of products and services.</p><p>But Amazon's biggest growth driver looks to be its cloud infrastructure segment Amazon Web Services (AWS). During the worst economic downturn in decades in 2020, AWS grew its sales by 30%. AWS currently has an annual revenue run-rate of $54 billion, and it's generating the bulk of Amazon's operating income despite accounting for only around an eighth of total sales.</p><p>Here's the kicker: Amazon ended every year in the 2010s at a multiple of 23 to 37 times its cash flow. With its operating cash flow expected to more than double by 2024 (thanks to AWS), Amazon is valued at just 10 times future forecasted cash flow. Moon launch imminent, folks.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Supercharged Stocks That Are Going to the Moon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Supercharged Stocks That Are Going to the Moon\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-07 23:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/07/5-supercharged-stocks-that-are-going-to-the-moon/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Although the year isn't even halfway over, it'll almost certainly be remembered as the year retail investors firmly asserted themselves on Wall Street.Since January, retail investors have effectively ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/07/5-supercharged-stocks-that-are-going-to-the-moon/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABNB":"爱彼迎","BARK":"The Original Bark Corp.","SE":"Sea Ltd","JUSHF":"Jushi Holdings Inc.","AMZN":"亚马逊","03086":"华夏纳指"},"source_url":"https://www.fool.com/investing/2021/06/07/5-supercharged-stocks-that-are-going-to-the-moon/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2141127236","content_text":"Although the year isn't even halfway over, it'll almost certainly be remembered as the year retail investors firmly asserted themselves on Wall Street.Since January, retail investors have effectively banded together to buy shares and out-of-the-money call options in stocks with very high levels of short interest. The intent of these retail groups is to effect a short squeeze -- a short-term event that sees pessimists (short-sellers) run for the exit at once, causing a company's share price to skyrocket -- and send these stocks \"to the moon.\"Unfortunately, nearly all of the companies retail traders have targeted have poor fundamental track records and/or frightening balance sheets. In short, these gains aren't going to be sustainable.If you want to own stakes in companies with a real chance of \"going to the moon,\" you have to buy into innovative businesses with tangible growth prospects. The following five supercharged stocks fit the bill perfectly.Sea LimitedGrowth stock investors who are patient will likely watch Singapore-based Sea Limited (NYSE:SE) go to the moon over the next decade. That's because Sea brings not one or even two, but three rapidly growing and differentiated operating segments to the table.For the time being, Sea's digital entertainment division is generating all of its earnings before interest, taxes, depreciation, and amortization (EBITDA). The company ended March with almost 649 million quarterly active gamers, 12.3% of which were paying customers. What's notable is that the number paying customers jumped from 8.9% in the year-ago quarter to 12.3%.However, the segment that'll create far more long-term value is its e-commerce shopping platform Shopee. The most downloaded e-commerce app in Southeastern Asia saw gross merchandise value more than double to $12.6 billion in Q1 2021, with gross orders up 153% to 1.1 billion. Even though the ongoing pandemic is helping funnel consumers into online channels, it's the rise of the middle class in emerging markets that'll be responsible for Sea's ascent.To round things out, Sea also has over 26 million paying mobile wallet customers. Since it operates in a number of underbanked countries, offering access to digital financial services could be another game-changer for the company and its consumers.Jushi HoldingsSmall-cap U.S. marijuana stock Jushi Holdings (OTC:JUSHF) also has a pretty good chance of shooting to the moon for long-term investors.By 2025, New Frontier Data has forecast more than $41 billion in annual U.S. weed sales. Like other multistate operators, Jushi is angling for its piece of this fast-growing pie. But it's doing so a bit differently. Most of its revenue is expected to come from Pennsylvania, Illinois, and Virginia. Why these three states? The answer is they all limit the number of retail licenses they issue. This is to say that Jushi is going to face limited or nonexistent competition in these states, which'll allow it to successfully build up its brand awareness and create a loyal following.Jushi is also well capitalized and not afraid to make acquisitions to bolster its retail or cultivation presence. It boosted its presence in Pennsylvania and Virginia earlier this year and recently closed on the purchase of two dispensaries in California. The Golden State is the largest pot market in the world, by annual sales.Most marijuana stocks are valued at anywhere between 3 and 7 times forward-year sales. As for Jushi, it can be scooped up for less than 2 times forward-year sales, which is a big-time bargain.AirbnbAnother innovative business that can moonshot higher over the long-run is stay-and-hosting platform Airbnb (NASDAQ:ABNB).Airbnb has the potential to completely transform the traditional hotel and travel industry. By the company's own admission, it has about 4 million hosts worldwide. But this is just the tip of the iceberg. There are around 130 million households just in the U.S., and likely well over 1 billion worldwide. Once people become aware of the cash flow potential of listing their property on Airbnb, we'll likely see this 4 million figure double many times over.Don't overlook Airbnb's role outside of its foundational hosting marketplace, either. The company's Experiences -- activities led by local experts -- represents just one of the many ways Airbnb can partner with hosts or popular travel destination businesses to sell inclusive packages and build customer loyalty.Maybe most impressive of all is how many people are familiar with Airbnb and its marketplace. Word-of-mouth advertising is a cheap yet powerful tool, and Airbnb has harnessed it perfectly to build a strong brand identity.The Original BARK CompanyThe Original BARK Company (NYSE:BARK), which officially completed its merger with a special purpose acquisition company (SPAC) last week, is another supercharged growth stock that has moonshot potential written all over it.The BARK Company, which is probably best known as BarkBox, provides dog-focused products and services to pet owners. Though you'll find its products in 23,000 retail doors, it's predominantly an e-commerce company that relies on high-margin subscriptions. As of the end of March, it had 1.2 million subscribers, which was up 91% from the prior-year period. What's more, the company's S-1 filing notes that monthly product retention is higher than it's ever been, which signifies that a high percentage of subscribers aren't cancelling.Innovation is also important for BARK. Last year, it introduced Bark Home, which allows dog owners to purchase basic-need accessories like collars and beds, and Bark Eats, a program that personalizes and delivers a high-quality dry food diet to dog owners.If this isn't convincing enough, consider that it's been more than a quarter of a century since year-over-year pet expenditures declined in the United States. This year alone, the American Pet Products Association expects nearly $110 billion will be spent on companion animals, $44.1 billion of which is on food and treats, which is BarkBox's specialty.AmazonLast but not least, e-commerce giant Amazon (NASDAQ:AMZN) can still go to the moon. You might be skeptical of one of the world's largest companies delivering outsized returns, but a closer inspection at its e-commerce dominance and cash flow will turn that skepticism into optimism.As you're likely aware, Amazon is the 800-pound gorilla in the U.S. online retail space. A recently released report from eMarketer estimates Amazon will control 40.4% of all e-commerce sales in the U.S. this year. Despite retail margins generally being razor thin, the company has been able to boost its revenue and grow its online dominance by selling over 200 million Prime subscriptions. The revenue collected from these memberships helps Amazon undercut brick-and-mortar retailers on price. And it certainly doesn't hurt that Prime members are incented to stay within the company's ecosystem of products and services.But Amazon's biggest growth driver looks to be its cloud infrastructure segment Amazon Web Services (AWS). During the worst economic downturn in decades in 2020, AWS grew its sales by 30%. AWS currently has an annual revenue run-rate of $54 billion, and it's generating the bulk of Amazon's operating income despite accounting for only around an eighth of total sales.Here's the kicker: Amazon ended every year in the 2010s at a multiple of 23 to 37 times its cash flow. With its operating cash flow expected to more than double by 2024 (thanks to AWS), Amazon is valued at just 10 times future forecasted cash flow. Moon launch imminent, folks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183345965,"gmtCreate":1623311327657,"gmtModify":1704200611863,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>to the moon","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>to the moon","text":"$ContextLogic Inc.(WISH)$to the moon","images":[{"img":"https://static.tigerbbs.com/c70e687b4721acec02f0439712d4b907","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183345965","isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":184966120,"gmtCreate":1623681230060,"gmtModify":1704208589933,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SKYT\">$SkyWater Technology, Inc.(SKYT)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/SKYT\">$SkyWater Technology, Inc.(SKYT)$</a>gogogo","text":"$SkyWater Technology, Inc.(SKYT)$gogogo","images":[{"img":"https://static.tigerbbs.com/3704c4f62374ea4eb5ab662eda4f1fb0","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184966120","isVote":1,"tweetType":1,"viewCount":277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":183342769,"gmtCreate":1623311288751,"gmtModify":1704200611700,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183342769","repostId":"2142248197","repostType":2,"repost":{"id":"2142248197","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623276530,"share":"https://ttm.financial/m/news/2142248197?lang=&edition=fundamental","pubTime":"2021-06-10 06:08","market":"us","language":"en","title":"BRIEF-AMC Entertainment Director Kathleen Pawlus Reports Open Market Sale Of 15,379 Class A Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2142248197","media":"Reuters","summary":"June 9 (Reuters) - AMC Entertainment Holdings Inc   :   * AMC ENTERTAINMENT'S DIRECTOR KATHLEEN PAWL","content":"<html><body><p>June 9 (Reuters) - AMC Entertainment Holdings Inc   :</p><p>   * AMC ENTERTAINMENT'S DIRECTOR KATHLEEN PAWLUS REPORTS OPEN MARKET SALE OF 15,379 CLASS A COMMON SHARES AT WEIGHTED AVERAGE PRICE OF $55.54/SHARE - FILING</p><p>Source text for Eikon: () Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-AMC Entertainment Director Kathleen Pawlus Reports Open Market Sale Of 15,379 Class A Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-AMC Entertainment Director Kathleen Pawlus Reports Open Market Sale Of 15,379 Class A Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-10 06:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>June 9 (Reuters) - AMC Entertainment Holdings Inc   :</p><p>   * AMC ENTERTAINMENT'S DIRECTOR KATHLEEN PAWLUS REPORTS OPEN MARKET SALE OF 15,379 CLASS A COMMON SHARES AT WEIGHTED AVERAGE PRICE OF $55.54/SHARE - FILING</p><p>Source text for Eikon: () Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142248197","content_text":"June 9 (Reuters) - AMC Entertainment Holdings Inc   :   * AMC ENTERTAINMENT'S DIRECTOR KATHLEEN PAWLUS REPORTS OPEN MARKET SALE OF 15,379 CLASS A COMMON SHARES AT WEIGHTED AVERAGE PRICE OF $55.54/SHARE - FILINGSource text for Eikon: () Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":260,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183342015,"gmtCreate":1623311222137,"gmtModify":1704200610240,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/183342015","repostId":"1100474066","repostType":4,"isVote":1,"tweetType":1,"viewCount":287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180956367,"gmtCreate":1623171571059,"gmtModify":1704197696900,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/UONE\">$Radio One(UONE)$</a>?","listText":"<a href=\"https://laohu8.com/S/UONE\">$Radio One(UONE)$</a>?","text":"$Radio One(UONE)$?","images":[{"img":"https://static.tigerbbs.com/601f8429dde8aea1b9dddc6cac99d943","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/180956367","isVote":1,"tweetType":1,"viewCount":162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":117051580,"gmtCreate":1623111153240,"gmtModify":1704196172430,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Gogogo","listText":"Gogogo","text":"Gogogo","images":[{"img":"https://static.tigerbbs.com/798a19ab6f13eec45c911a67c89f5823","width":"1080","height":"2930"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117051580","isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":117029565,"gmtCreate":1623110817957,"gmtModify":1704196157359,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OEG\">$Orbital Energy Group(OEG)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/OEG\">$Orbital Energy Group(OEG)$</a>gogogo","text":"$Orbital Energy Group(OEG)$gogogo","images":[{"img":"https://static.tigerbbs.com/2dfe21dedb96b6f6d50d48a5c84c94ac","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/117029565","isVote":1,"tweetType":1,"viewCount":223,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":114549971,"gmtCreate":1623081931293,"gmtModify":1704195774058,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"Go","listText":"Go","text":"Go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114549971","repostId":"1108033863","repostType":4,"repost":{"id":"1108033863","pubTimestamp":1623087360,"share":"https://ttm.financial/m/news/1108033863?lang=&edition=fundamental","pubTime":"2021-06-08 01:36","market":"us","language":"en","title":"FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades","url":"https://stock-news.laohu8.com/highlight/detail?id=1108033863","media":"cnbc","summary":"(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer","content":"<div>\n<p>(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer's drug aducanumab, making it the first drug cleared by U.S. regulators to slow cognitive decline in...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA approves Biogen's Alzheimer's drug, the first new therapy for the disease in nearly two decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-08 01:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer's drug aducanumab, making it the first drug cleared by U.S. regulators to slow cognitive decline in...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.cnbc.com/2021/06/07/fda-approves-biogens-alzheimers-drug-the-first-new-therapy-for-the-disease-in-nearly-two-decades.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1108033863","content_text":"(June 7) Biogen surged nearly 60%.The Food and Drug Administration on Monday approvedBiogenAlzheimer's drug aducanumab, making it the first drug cleared by U.S. regulators to slow cognitive decline in people living with Alzheimer's and the first new medicine for the disease in nearly two decades.The FDA's decision was highly anticipated. The drug, which is marketed under the name Aduhelm, is also expected to generate billions of dollars in revenue for the company.\"We are well-aware of the attention surrounding this approval,\" Dr. Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, said in a press release. \"We understand that Aduhelm has garnered the attention of the press, the Alzheimer's patient community, our elected officials, and other interested stakeholders.\"\"With a treatment for a serious, life-threatening disease in the balance, it makes sense that so many people were following the outcome of this review,\" Cavazzoni added.Alzheimer’s disease is a progressive neurodegenerative disorder that slowly destroys memory and thinking skills. More than 6 million Americans are living with the disease, according toestimates by the Alzheimer’s Association.By 2050, that number is projected to rise to nearly 13 million, according to the group.There were previously no drugs cleared by the FDA that can slow the mental decline from Alzheimer’s, which is the sixth leading cause of death in the United States. The U.S. agency has approved Alzheimer’s drugs aimed at helping symptoms, not actually slowing the disease itself.Federal regulators have faced intense pressure from friends and family members of Alzheimer’s patients asking to fast-track aducanumab, but the road to regulatory approval has been a controversial one since it showed promise in 2016.In March of 2019, Biogen pulled work on the drug after an analysis from an independent group revealed it was unlikely to work. The company then shocked investors several months later by announcing it would seek regulatory approval for the drug after all.Shares of Biogen soared in Novemberafter it won backing from FDA staff, who said the company showed highly “persuasive” evidence aducanumab was effective and that it had “an acceptable safety profile that would support use in individuals with Alzheimer’s disease.”But two days later, a panel of outside experts that advises theU.S. agency unexpectedly declined to endorsethe experimental drug, citing unconvincing data. It also criticized agency staff for what it called an overly positive review.When Biogen sought approval for the drug in late 2019, its scientists said a new analysis of a larger data set showed that aducanumab “reduced clinical decline in patients with early Alzheimer’s disease.”Alzheimer’s experts and Wall Street analysts were immediately skeptical, with some wondering whether the clinical trial data was enough to prove that the drug works and whether approval could make it harder for other companies to enroll patients in their own drug trials.Some doctorshave said they won’t prescribethe drug if it does reach the market, because of the mixed data package supporting the company’s application.Supporters, including advocacy groups and family members of those living with the disease desperate for a new treatment, have acknowledged that the data isn’t perfect. However, they argue that it could help some patients with Alzheimer’s, a progressive and debilitating disease.Biogen’s drug targets a “sticky” compound in the brain known as beta-amyloid, which scientists expect plays a role in the devastating disease. The company has previously estimated about 1.5 million people with early Alzheimer’s in the U.S. could be candidates for the drug, according to Reuters.The FDA decision is expected to reverberate throughout the biopharma sector, RBC Capital Markets analyst Brian Abrahams said in a note to clients on June 1.The U.S. agency said Monday it determined there was “substantial evidence” the drug helps patients.“As a result of FDA’s approval of Aduhelm, patients with Alzheimer’s disease have an important and critical new treatment to help combat this disease,” it said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":114256244,"gmtCreate":1623076734988,"gmtModify":1704195626142,"author":{"id":"3562230741987077","authorId":"3562230741987077","name":"肥猫发发","avatar":"https://static.tigerbbs.com/3fc7372e5d9e18b752cc26cb4b2233d3","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3562230741987077","idStr":"3562230741987077"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogogo","listText":"<a href=\"https://laohu8.com/S/SKLZ\">$Skillz Inc(SKLZ)$</a>gogogo","text":"$Skillz Inc(SKLZ)$gogogo","images":[{"img":"https://static.tigerbbs.com/643055b717fd2a0e305c56043dc126d5","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114256244","isVote":1,"tweetType":1,"viewCount":67,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}